ESPE Abstracts

Contents

• Plenary Lectures
• • Oncofertility: From Bench to Bedside to Babies
  • • Oncofertility: From Bench to Bedside to Babies

      hrp0089pl1
  • Oxytocin and the healing power of love
  • • Oxytocin and the Healing Power of Love

      hrp0089pl2
  • Clinical and molecular genetics of corticothroph pituitary tumours (Cushings Disease)
  • • Abstract unavailable

      hrp0089pl3
  • Prediction, Identification, and Treatment of Early Stage Type 1 Diabetes
  • • Abstract unavailable

      hrp0089pl4
  • Dynamic control of tissue glucocorticoids - lessons for optimising replacement therapy
  • • Dynamic Control of Tissue Glucocorticoids - Lessons for Optimising Replacement Therapy

      hrp0089pl5
  • Personalized treatments using gut microbiome and clinical data
  • • Personalizing Treatments Using Microbiome and Clinical Data

      hrp0089pl6
  • New curative treatment strategies for Type 1 Diabetes
  • • Abstract unavailable

      hrp0089pl7
  • Turner syndrome: new insights from prenatal genomics and transcriptomics
  • • Turner Syndrome: New Insights from Prenatal Genomics and Transcriptomics

      hrp0089pl8
• Symposia
• • Recent developments in the understanding of Hypothalamo-pituitary disorders
  • • Molecular Basis of Pituitary Hormone Deficiency: From Mouse to Man and Back

      hrp0089s1.1
    • Stem Cells in the Pituitary: A Role for Regeneration?

      hrp0089s1.2
    • A Novel Role for Vasopressin in Parenting

      hrp0089s1.3
  • Gonads/DSD
  • • The Biology of Germ Cell Tumors in Disorders of Sex Development

      hrp0089s2.1
    • Disruption of Testicular Development and Function

      hrp0089s2.2
    • Abstract unavailable

      hrp0089s2.3
  • Recent consensus guidelines
  • • Diagnosis and Management of Silver-Russell Syndrome: First International Consensus Statement

      hrp0089s3.1
    • Abstract unavailable

      hrp0089s3.2
    • Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline

      hrp0089s3.3
    • Prevention and Management of Rickets

      hrp0089s3.4
  • Management of Late Effects of Cancer Therapy
  • • Abstract unavailable

      hrp0089s4.1
    • Hypogonadism in Girls after Cancer Therapy: Causes, Diagnosis, and Treatment

      hrp0089s4.2
    • Diagnosis and Treatment of Hypogonadism in Male Survivors of Childhood Cancer

      hrp0089s4.3
  • ISPAD - ESPE Preventing Late Complications in Children with T1D
  • • Abstract unavailable

      hrp0089s5.1
    • Re-defining Targets for Optimal T1D Control

      hrp0089s5.2
    • Abstract unavailable

      hrp0089s5.3
  • Molecular Mechanisms of Tissue Sensitivity to Glucocorticoids: Potential Clinical Implications
  • • Cardiomyocyte Glucocorticoid and Mineralocorticoid Receptors Antagonistically Regulate Heart Disease

      hrp0089s6.1
    • Immune Regulation by Glucocorticoids

      hrp0089s6.2
    • Chemical Modification of the Glucocorticoid Receptor as a Determinant of Tissue Glucocorticoid Sensitivity: Implications to Circadian Rhythms, Stress Response and Treatment of Pediatric Leukemia

      hrp0089s6.3
  • Bone
  • • X-linked Hypophosphataemic Rickets: Disease and Treatment

      hrp0089s7.1
    • Hypophosphatasia: Disease and Treatment

      hrp0089s7.2
    • Achondroplasia - New Hopes

      hrp0089s7.3
  • Thyroid disorders
  • • Thyroid Hormone Transporter Defects

      hrp0089s8.1
    • Central Hypothyroidism - an Update

      hrp0089s8.2
    • Paediatric Differentiated Thyroid Cancer: Outcome and Long Term Effects

      hrp0089s8.3
  • Novel advances in endocrine imaging
  • • Abstract unavailable

      hrp0089s9.1
    • Novel CNS Imaging Techniques

      hrp0089s9.2
    • Novel Techniques in Diagnostics of Bone Strength

      hrp0089s9.3
  • Paediatric obesity: Mechanisms and novel treatment
  • • Abstract unavailable

      hrp0089s10.1
    • Functional Leptin Deficiency Disorders and Treatment

      hrp0089s10.2
    • MC4R Agonists in the Treatment of Monogenic Disorders of Obesity

      hrp0089s10.3
  • Special Symposia: Nutrition and Growth
  • • It is not Just the Growth Hormone-IGF-I Axis

      hrp0089ss1.1
    • Fascinating Growth Phenomena: What Causes Individual Catch-up Growth and Population Secular Change?

      hrp0089ss1.2
    • Interaction between Nutrition, the Endocrine System and the Growth Plate

      hrp0089ss1.3
• Meet the Expert
• • The Role of Radiology in the Diagnosis of Skeletal Dysplasias
  • • The Role of Radiology in the Diagnosis of Skeletal Dysplasias

      hrp0089mte1.1
  • Endocrine Complications in Thalassaemia
  • • Endocrine Complications in Thalassaemia

      hrp0089mte2.1
  • (1) (1)
  • • Abstract unavailable

      hrp0089mte3.1
  • The Use of Modern Technologies to Optimize Diabetes Care
  • • The Use of Modern Technologies to Optimize Diabetes Care

      hrp0089mte4.1
  • Gonadal function in congenital adrenal hyperplasia (CAH)
  • • Gonadal Function in Congenital Adrenal Hyperplasia (CAH)

      hrp0089mte5.1
  • Management of Hypo and Hypercalcaemia
  • • Management of Hypo and Hypercalcaemia

      hrp0089mte6.1
  • (1)
  • • Abstract unavailable

      hrp0089mte7.1
  • Psychology of childhood diabetes: How to motivate children and families with T1DM
  • • Psychology of Childhood Diabetes: How to Motivate Children and Families with T1DM

      hrp0089mte8.1
• Novel Advances & Controversies in Paediatric Endocrinology
• • The clinical relevance of metabolomics; genomic engineering - CRISP-R/Cas9 and its many implications
  • • The Clinical Relevance of Metabolomics

      hrp0089na1.1
    • Abstract unavailable

      hrp0089na1.2
  • Cell engineering for treatment of diabetes
  • • Stem Cells as a Source of Beta Cells

      hrp0089na2.1
    • Induction of Pancreatic Beta-Cell Neogenesis

      hrp0089na2.2
  • Should growth hormone be used in ISS?
  • • PRO: Should GH Be Used in ISS?

      hrp0089con1.1
    • Abstract unavailable

      hrp0089con1.2
    • Abstract unavailable

      hrp0089con1.3
    • Abstract unavailable

      hrp0089con1.4
  • To prime or not to prime?
  • • PRO - To Prime or Not to Prime?

      hrp0089con2.1
    • Con-To Prime or Not to Prime

      hrp0089con2.2
• Henning Anderson Award
• • EAP1 mutations cause an impaired transcriptional activity on GnRH promoter that leads to self-limited delayed puberty
  • • EAP1 Mutations Cause an Impaired Transcriptional Activity on GnRH Promoter that Leads to Self-Limited Delayed Puberty

      hrp0089ha1
  • Generating a human gonadal cells model from terminal differentiated fibroblast-derived induced pluripotent stem cells
  • • Generating a Human Gonadal Cells Model from Terminal Differentiated Fibroblast-Derived Induced Pluripotent Stem Cells

      hrp0089ha2
• Working Groups
• • ESPE Disorders of Sex Development & Turner Syndrome Joint Session
  • • Long-Term Outcomes in Males with 45,X/46,XY Mosaicism: A Multicenter Study of 59 Males

      hrp0089wg1.1
    • Abstract unavailable

      hrp0089wg1.2
    • Cardiovascular Pathology in Males and Females with 45,X/46,XY Mosaicism

      hrp0089wg1.3
    • Abstract unavailable

      hrp0089wg1.4
    • Abstract unavailable

      hrp0089wg1.5
    • Abstract unavailable

      hrp0089wg1.6
  • ESPE Obesity Working Group (OWG)
  • • Abstract unavailable

      hrp0089wg2.1
    • Abstract unavailable

      hrp0089wg2.2
    • Abstract unavailable

      hrp0089wg2.3
    • Abstract unavailable

      hrp0089wg2.4
  • ESPE Bone and Growth Plate Working Group (BGP)
  • • Abstract unavailable

      hrp0089wg3.1
    • SHOX - From Gene to Growth Plate

      hrp0089wg3.2
    • Abstract unavailable

      hrp0089wg3.3
    • Abstract unavailable

      hrp0089wg3.4
    • Abstract unavailable

      hrp0089wg3.5
    • Abstract unavailable

      hrp0089wg3.6
  • ESPE Diabetes Technology and Therapeutics Working Group
  • • Abstract unavailable

      hrp0089wg4.1
    • Abstract unavailable

      hrp0089wg4.2
    • Use of Apps for Physical Activity in Type 1 Diabetes

      hrp0089wg4.3
    • The Future Role of Machine Learning and Computer Vision in Carbohydrate Estimation for Patients with Diabetes

      hrp0089wg4.4
    • Analyzing and Reporting of Sensor Glucose Levels

      hrp0089wg4.5
    • Updates on the Developments of Decision Support Systems for the Treatment of Diabetes

      hrp0089wg4.6
    • Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes

      hrp0089wg4.7
  • ESPE Paediatric and Adolescent Gynaecology Working Group (PAG)
  • • Abstract unavailable

      hrp0089wg5.1
    • Abstract unavailable

      hrp0089wg5.2
    • Influence of Adiposity as a Determinant of the Age at Pubjeanertal Onset

      hrp0089wg5.3
    • Endocrine-Metabolic Outcome of Women with a History of Sexual Precocity

      hrp0089wg5.4
    • Abstract unavailable

      hrp0089wg5.5
  • ESPE Gender Dysphoria (GD)
  • • Abstract unavailable

      hrp0089wg6.1
    • Abstract unavailable

      hrp0089wg6.2
  • ESPE Paediatric Endocrine Nurse Specialists and Allied Health Professionals Working Group (PENS)
  • • Advanced Anthropometrics in Pediatric Endocrinology: Utility and Difficulty

      hrp0089wg7.1
    • Next Generation Nursing: Genomic Competencies for Pediatric Endocrine Nurses

      hrp0089wg7.2
    • Abstract unavailable

      hrp0089wg7.3
    • Abstract unavailable

      hrp0089wg7.4
    • Abstract unavailable

      hrp0089wg7.5
• Free Communications
• • Adrenals & HPA Axis
  • • A Novel Non-invasive Short Synacthen Test Validated in a Healthy Paediatric Population

      hrp0089fc1.1
    • Long-term Effects of Prenatal Dexamethasone Treatment and Postnatal Glucocorticoid Treatment on Brain Structure in the Context of CAH

      hrp0089fc1.2
    • Targetting the Binding of ACTH to the Melanocortin Receptor by Structure Modeling and Design of Peptide antagonists to Block Excess Androgens in 21-hydroxylase Deficiency

      hrp0089fc1.3
    • Whole Exome Sequencing in Patients with Primary Generalized Glucocorticoid Resistance Identifies a Novel TRIM28 Gene Mutation (p.R230X)

      hrp0089fc1.4
    • Untargeted Plasma Metabolomics in Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel metabolic Signature

      hrp0089fc1.5
    • A Novel Stem Cell Model for the Triple A Syndrome

      hrp0089fc1.6
  • Bone, Growth Plate & Mineral Metabolism 1
  • • Burosumab, a Fully Human anti-FGF23 Monoclonal Antibody, for X-linked Hypophosphatemia (XLH): Sustained Improvement in two Phase 2 Trials in Affected Children 1-12 years old

      hrp0089fc2.1
    • Whole Genome Sequencing Reveals Novel Intragenic Deletions of GNAS as Causes of Pseudohypoparathyroidism Type 1a

      hrp0089fc2.2
    • Clinical Course of Hypoparathyroidism in Patients with APECED (APS1)

      hrp0089fc2.3
    • Diagnostic Performance of Artificial Neural Network-based TW3 Skeletal Maturity Assessment

      hrp0089fc2.4
    • Radial ESWT Stimulates Longitudinal Bone Growth in Cultured Rat Fetal Metatarsal Bones

      hrp0089fc2.5
    • Final Height is Negatively Related to Disease Burden in Mitochondrial Disease

      hrp0089fc2.6
  • Diabetes and Insulin 1
  • • Neonatal Diabetes Owned to Potassium Channel Mutation: Response to Sulfonylureas According to the Genotype

      hrp0089fc3.1
    • Genome-Wide Meta-Analysis Identifies a Novel Low Frequency STK39 Variant of Large Effect on Risk of Type 1 Diabetes

      hrp0089fc3.2
    • Pediatric Patients with Type 1 Diabetes and Abnormal Nerve Conduction Studies Demonstrate Higher Neopterin Levels: Potential Role as a Biochemical Marker for Peripheral Neuropathy

      hrp0089fc3.3
    • Is the Glycaemic Response from Fat in Meals Dose Dependent in Children and Adolescents with T1DM on Intensive Insulin Therapy?

      hrp0089fc3.4
    • Genotype and Phenotype Correlation in Syndromic Forms of Hyperinsulinaemic Hypoglycaemia - a 10-year follow-up Study in a Tertiary Centre

      hrp0089fc3.5
    • Using CRISPR/Cas9 Gene Editing to Study the Molecular Genetics of Congenital Hyperinsulinism

      hrp0089fc3.6
  • GH & IGFs
  • • Monogenic and Digenic Gene Mutations are Present in Children with Idiopathic Short Stature (ISS)

      hrp0089fc4.1
    • Effects of IGF-1R Nuclear Localization in Glioblastoma Cells

      hrp0089fc4.2
    • The Reduction in Longitudinal Growth Induced By PAPP-A2 Deficiency is Associated with Reduced Body Weight, Increased Energy Expenditure and Behavior Modification

      hrp0089fc4.3
    • A Cross-Sectional Study of IGF-I Bioavailability Through Childhood and Associations with PAPP-A2, STC2 and Anthropometric Data

      hrp0089fc4.4
    • Prediction of Adult Height by Artificial Intelligence (AI) through Machine Learning (ML) from Early Height Data

      hrp0089fc4.5
    • Absorption and Excretion of Somapacitan, a Long-Acting Growth Hormone (GH) Derivative

      hrp0089fc4.6
  • Thyroid
  • • Beta1-Tubulin Gene (TUBB1) Mutations Cause Thyroid Dysgenesis Associated to Abnormal Platelet Morphology and Hyper-Aggregation

      hrp0089fc5.1
    • Enrichment of Inherited Rare Variants in Non-Syndromic Congenital Hypothyroidism from Thyroid Dysgenesis Identified By Exome Sequencing: the Contribution of IKBKE to Vasculogenesis and Thyroid Development

      hrp0089fc5.2
    • Computational Analysis of the Ligand Binding Domain of the Thyroid Hormone Receptor for the Rational Design of an Efficient Protein-Based Biosensor for the Detection of Thyroid Hormone Disrupting Chemicals

      hrp0089fc5.3
    • Thyroid Hormone Analog Therapy in Patients with MCT8 deficiency: the Triac Trial

      hrp0089fc5.4
    • Guidelines for the Management of Paediatric Differentiated Thyroid Carcinoma; a UK Endeavour

      hrp0089fc5.5
    • Alterations in DNA Methylation Status of Gene Promoters in Children and Adolescents with Autoimmune Thyroid Disease

      hrp0089fc5.6
  • Fat, Metabolism and obesity
  • • Correlations Between Measures of Adiposity Across Childhood and Adolescence and the Intestinal Microbiota in 15-17 year-old Children with a Family History of Obesity: Preliminary Findings from the QUALITY Cohort

      hrp0089fc6.1
    • Impaired Brain Satiety Responses to a Meal in Children with Obesity

      hrp0089fc6.2
    • Role of PTEN in the Proliferation and Differentiation of Preadipocytes

      hrp0089fc6.3
    • Identification of the First Obesity-Associated Mutations in Human Mesoderm-Specific Transcript (MEST) Result in Protein Overexpression, Adipocyte Hypertrophy and a Reduction in Adipocyte Mitochondrial Area

      hrp0089fc6.4
    • The Role of Adipocytes in Childhood Precursor Bcell Lymphoblastic Leukemia

      hrp0089fc6.5
    • MicroRNA-141 Directly Targets and Inhibits Sirtuins 1 Gene Expression and Its Elevation in Obese Subjects is Responsible for Reduced Levels of Sirtuin 1 and the Subsequent Hepatic Steatosis and Insulin Resistance

      hrp0089fc6.6
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism

      hrp0089fc7.1
    • Enteroinsular Hormone Responses During Fasting, Oral glucose Tolerance Test and Mixed Meal in Children with Hyperinsulinaemic Hypoglycaemia

      hrp0089fc7.2
    • Diazoxide-Induced Pulmonary Hypertension: UK Multicentre Retrospective Study on the Risk Factors, Monitoring Approach and Management Recommendations

      hrp0089fc7.3
    • Altered Substrate Specificities and Metabolite Production by Aromatase (CYP19A1) Due to the R192H Mutation

      hrp0089fc7.4
    • Thyroid Hormone Levels in Cord Blood are Associated with Fetal and Neonatal Growth

      hrp0089fc7.5
    • TSH-Resistance and Remaining Low-T4 in Former Low-Birthweight Infants - A Study in Monozygotic Twins with Intra-Twin Birth-Weight-Differences

      hrp0089fc7.6
  • Sex differentiation, Gonads and Gynaecology or Sex Endocrinology
  • • Estrogen Receptor 2 Variant as a Novel Cause for Dysgenetic Ovaries

      hrp0089fc8.1
    • Partial Restoration of Biological Effects of Estrogen in a Female with Estrogen Receptor [alpha] Variant

      hrp0089fc8.2
    • Exomic Sequencing Uncovers Novel Genetic Associations for Deciphering Developmental Disorders (DDD) Study Participants with Hypospadias, Cardiovascular and Neurodevelopmental Abnormalities

      hrp0089fc8.3
    • STARD8, a Novel Candidate Gene for 46,XY Disorders of Sex Development

      hrp0089fc8.4
    • DEAH-Box Helicase 37defects (DXH37) Deffects are a Novel Cause of 46,XY Gonadal Dysgenesis

      hrp0089fc8.5
    • The Roles of Steroids in Gonadal Development and Maintenance - Insights from a Zebrafish Model of Androgen and Cortisol Deficiency

      hrp0089fc8.6
  • Pituitary, neuroendocrinology and Puberty 1
  • • Novel Variants in the POU1F1 Beta Isoform are Associated with Isolated Growth Hormone Deficiency and Combined Pituitary Hormone Deficiency

      hrp0089fc9.1
    • Contribution of Functionally Assessed GHRHR Mutations to Idiopathic Isolated Growth Hormone Deficiency in a Cohort of 312 Unrelated Patients

      hrp0089fc9.2
    • Mutations in MAGEL2 and L1CAM are Associated with Congenital Hypopituitarism and Arthrogryposis

      hrp0089fc9.3
    • Neuroendocrine Morbidity after Paediatric Craniopharyngioma: a Longitudinal Single Centre Analysis of 93 Patients Over 30 Years

      hrp0089fc9.4
    • National Multidisciplinary Decision-Making Guideline for Children and Young People (Idiopathic Thickened Pituitary Stalk and/or Idiopathic Central Diabetes Insipidus

      hrp0089fc9.5
    • National UK Guidelines for Screening, Multi-Disciplinary Team Management and Long-Term Follow-Up of Children and Young People (CYP) with Multiple Endocrine Neoplasia Type 1 (MEN1)

      hrp0089fc9.6
  • Late Breaking
  • • Burosumab Improved Rickets, Phosphate Metabolism, and Clinical Outcomes Compared to Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) - A Randomized Controlled Phase 3 Study

      hrp0089fc10.1
    • Efficacy and Safety of Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Results of a Randomised Open-Label, Controlled Phase 2 Trial

      hrp0089fc10.2
    • Identification of the MAPK/ERK Pathway as a Novel Therapeutic Target in Adamantinomatous Craniopharyngioma

      hrp0089fc10.3
    • Hypothalamus Sparing Surgery Improves the Outcome of Patients with Severe Initial Hypothalamic Involvement of Childhood Craniopharyngioma: Results of the Prospective Multinational Trial KRANIOPHARYNGEOM 2007

      hrp0089fc10.4
    • A 5-Year Single-Centre Experience on the Safety and Efficacy of Sirolimus Therapy used for the Treatment of Congenital Hyperinsulinaemic Hypoglycaemia

      hrp0089fc10.5
    • Primary Ovarian Insufficiency Incidence Rate and ETIOLOGY AMONG ISRAELI ADOLESCENTS between the Years 2000-2016 - A Multi-Center Study

      hrp0089fc10.6
  • Bone, Growth Plate & Mineral Metabolism 2
  • • Successful Immune Tolerance Induction in the First Case of Neutralizing Antibody Mediated Loss of Efficacy of Asfotase Alfa Treatment in Hypophosphatasia

      hrp0089fc11.1
    • Elevated Phosphate Levels Inhibit Skeletal Muscle Cell Differentiation In vitro

      hrp0089fc11.2
    • Evidence for Effects of FGF2 Aptamer in an Achondroplasia Mice Model and an In Vitro Chondrocyte Differentiation System Using Patient-Derived iPS Cells

      hrp0089fc11.3
    • Using Patient Derived Induced Pluripotent Stem Cells to Model Multiple Epiphyseal Dysplasia

      hrp0089fc11.4
    • A Recurrent 6-bp Intronic Deletion in NESP55 with Reduced Penetrance in Pseudohypoparathyroidism Type 1b

      hrp0089fc11.5
    • Management of Severe, Protracted Hypocalcaemia in Patients Undergoing Thymus Transplantation in a Tertiary Centre: A 10-Year Experience

      hrp0089fc11.6
  • Diabetes and Insulin 2
  • • Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Children and Adolescents: A Multicenter Prospective Study

      hrp0089fc12.1
    • Apoptosis and Oxidative Stress Markers During the Oral Glucose Tolerance Test (OGTT)

      hrp0089fc12.2
    • Impact of Insulin Sensitivity and [beta]-cell Function on the Development of Impaired Glucose Tolerance (IGT) in Obese European Children and Adolescents

      hrp0089fc12.3
    • How Does Thiol/Disulphide Homeostasis Change in Children with Type 1 Diabetes Mellitus?

      hrp0089fc12.4
    • Effect of Homocysteine-Lowering Therapy on Diabetic Nephropathy in children and adolescents with Type 1 Diabetes

      hrp0089fc12.5
    • Persistent Beneficial Effects of Metformin in Children and Adolescents with Type 1 Diabetes: Adelaide Metformin Randomized Controlled Trial Follow Up

      hrp0089fc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Molecular Screening of Genes Associated with Central Precocious Puberty

      hrp0089fc13.1
    • Ablation of AgRP Neurons Decreases Survival in Activity-Based Anorexia Model

      hrp0089fc13.2
    • Role of GnRH Neuronal Migration and Development in Self-Limited Delayed Puberty

      hrp0089fc13.3
    • The Kallman Syndrome Gene Product is Specifically Expressed in ACTH-Expressing Cells and Dysplays Sexual Dimorphism Expression in Human Fetal Pituitary

      hrp0089fc13.4
    • Study of the Serum Kisspeptin Level in Healthy and Hypogonadotropic Boys

      hrp0089fc13.5
    • Teamwork Saves Lives: How Pediatric Multidisciplinary care can Prevent 'Unexplained Deaths' in Adults with Prader-Willi Syndrome

      hrp0089fc13.6
  • Multisystem Endocrine Disorders
  • • Awareness and Participation in Rare Disease Registries Within the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

      hrp0089fc14.1
    • National UK Guidelines for the Clinical Assessment, Diagnosis, Treatment and Follow-up of Children and Young People (CYP) Under 19 Years of Age with Phaeochromocytoma (PCC) and Paraganglioma (PGL) - On Behalf of the UK Paediatric Phaeochromocytoma and Paraganglioma Guideline Development Group (GDG)

      hrp0089fc14.2
    • Regulation of Salt, Sugar and Sex Steroids in Humans by Genetic Variations in NADPH Cytochrome P450 Oxidoreductase (POR) Identified in 1000 Genome Samples

      hrp0089fc14.3
    • Glucocorticoid Deficiency Causes Differentially Dysregulated Oxidative Stress Depending on the Steroidogenic Defects

      hrp0089fc14.4
    • Pubertal Females Produce an Enhanced Interferon-Alpha, Anti-viral Response Compared to Males, Which is Associated with X Chromosome Number, and Not Sex Hormones

      hrp0089fc14.5
    • Sex Differences in Autoimmune Disease: Testosterone is Associated with a Decrease in Expression of Key Anti-viral Genes During Puberty, Which may Decrease the Risk of Autoimmunity in Males

      hrp0089fc14.6
  • Growth and Syndromes
  • • The Diagnostic Yield of a Targeted Next Generation Sequencing Panel in Children with Short Stature of Undefined Aetiology

      hrp0089fc15.1
    • Effects of Caloric Restriction During Gestation on the Methylome of Offspring's Adipose Tissue and Reversibility of Such Effects by Metformin in a Swine Model

      hrp0089fc15.2
    • Methylation of the C19MC microRNA Locus in the Placenta: A Mechanism whereby Maternal Body Size Links to that of the Child

      hrp0089fc15.3
    • The Metabolic Profile Associated with RASopathies

      hrp0089fc15.4
    • Utility of BDNF and MMP-1 as Markers of Cardiometabolic Risk in Turner Syndrome Girls

      hrp0089fc15.5
    • Vosoritide for Children with Achondroplasia:a 30 Month Update from an Ongoing Phase 2 Clinical Trial

      hrp0089fc15.6
• Rapid Free Communications
• • Adrenals & HPA Axis
  • • The Relative Contributions of Genetic and Environmental Factors on Cortisol Metabolism at Pre-, Mid- and Post-Pubertal Ages

      hrp0089rfc1.1
    • Changes in CYP19A1 and CYP3A4 Activities due to Population Genetic Variations in Human P450 Oxidoreductase

      hrp0089rfc1.2
    • Sphingosine-1-Phosphate Lyase (SGPL1) Deficiency is Associated with Mitochondrial Dysfunction

      hrp0089rfc1.3
    • Mass Spectrometry-Based Assessment of Childhood Androgen Excess in 487 Consecutive Patients Over 5 Years

      hrp0089rfc1.4
    • Quantitative Urinary GC-MS Based Steroid Analysis for Treatment Monitoring of Adolescents and Young Adults with Autoimmune Primary Adrenal Insufficiency

      hrp0089rfc1.5
    • A Laboratory Harmonization Strategy for Steroid Hormone Profiling by MoM-Transformed, Normalized Reference Ranges Independent of Age, Sex and Units

      hrp0089rfc1.6
  • Bone, Growth Plate & Mineral Metabolism 1
  • • High-Resolution MRI Imaging of Bone-Muscle-Fat in Glucocorticoid Treated Boys with Duchenne Muscular Dystrophy: Results from the ScOT-DMD Study

      hrp0089rfc2.1
    • S-25OHD is Associated with Hand Grip Strength and Myopathy at Five Years in Girls: An Odense Child Cohort Study

      hrp0089rfc2.2
    • Measured Free 25-Hydroxyvitamin D in Healthy Children and Relationship to Total 25-Hydroxyvitamin D, Calculated Free 25-Hydroxyvitamin D and Vitamin D Binding Protein

      hrp0089rfc2.3
    • Novel Severe Skeletal Dysplasia with Under-Mineralisation Associated with Reduced In Utero Calcium Transport and TRPV6 Compound Heterozygous Variants

      hrp0089rfc2.4
    • Identification of Characteristic Neurological Complications in Infants with Achondroplasia by Routine MRI Screening

      hrp0089rfc2.5
    • The Novel R211Q POP1 Homozygous Mutation Causes Severe Short Stature But Uniquely Only Subtle Skeletal Dysplasia

      hrp0089rfc2.6
  • Diabetes and Insulin 1
  • • Diagnostics of Early Atherosclerosis Risk in Kids (DEAR-Kids): Retinal Vessel Analysis in Pediatric Type 1 Diabetes - Retinal Arteriolar Narrowing Caused By High HbA1c

      hrp0089rfc3.1
    • Personalized and Predictive Medicine for Pediatric Diabetes Through a Genetic Test Using Next Generation Sequencing

      hrp0089rfc3.2
    • Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score

      hrp0089rfc3.3
    • Functional Characterization of a Novel KLF11 Mutation Identified in a Family with Autoantibody-Negative Type 1 Diabetes

      hrp0089rfc3.4
    • Recent Secular Change in Pre- and Postnatal Growth and Adiposity in Infants of Mothers with Gestational Diabetes

      hrp0089rfc3.5
    • Treatment Adherence and Weight Loss are Key Predictors of HbA1c One Year after Diagnosis of Childhood Type 2 Diabetes in UK

      hrp0089rfc3.6
  • GH & IGFs
  • • Abstract unavailable

      hrp0089rfc4.7
    • Data Mining and Computational Analysis of Human Growth Hormone Gene (GH1) Sequence in Normal Population to Identify Potential Variants with Disease-Causing Effects

      hrp0089rfc4.2
    • A Deletion Encompassing Exon 2 of the ALS Gene: Analysis of a Patient with ALS Deficiency and His Family

      hrp0089rfc4.3
    • A Longitudinal Study on miRNAs Circulating Levels in a Cohort of SGA and AGA Subjects, Evaluated During Childhood and Young Adulthood

      hrp0089rfc4.4
    • 12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency

      hrp0089rfc4.5
    • Effect of 2 Years of Growth Hormone Treatment on Glucose Tolerance in Adults with Prader-Willi Syndrome

      hrp0089rfc4.6
  • Thyroid
  • • Serum Levels of the Soluble Receptor for Advanced Glycation End Products are Reduced in Children with Hashimoto's Thyroiditis

      hrp0089rfc5.1
    • Analysis of Chosen Polymorphisms rs7138803 A/G - FAIM2, rs7093069 C/T - IL-2RA, rs5742909 C/T - CTLA-4 in Pathogenesis of Hashimoto's Thyroiditis in Children

      hrp0089rfc5.2
    • Incidence and Treatment Outcome of Childhood Thyrotoxicosis

      hrp0089rfc5.3
    • The Value of Cytological, Histological and US Examination to Determine of Management Children with Nodular Goiter

      hrp0089rfc5.4
    • Evidence for a Founder Effect in Multiple Endocrine Neoplasia 2

      hrp0089rfc5.5
    • DUOX2 Deficiency in Quebec: From Life-Threatening Compressive Goiter in Infancy to Lifelong Euthyroidism

      hrp0089rfc5.6
  • Fat, Metabolism and Obesity
  • • Abstract unavailable

      hrp0089rfc6.7
    • IGF-I at Four Months Associates to Visceral and Subcutaneous Adipose Tissue at 7 Years of Age

      hrp0089rfc6.2
    • Effect of the Melanocortin-4 Receptor Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Bardet-Biedl Syndrome

      hrp0089rfc6.3
    • Functionality and Phenotypic Characteristics of Mutations in the Human Leptin Receptor

      hrp0089rfc6.4
    • High-Throughput Untargeted Plasma Metabolomics Unravels Gender Dimorphic Metabolic Trajectories in Naturally Conceived and ICSI Prepubertal Children

      hrp0089rfc6.5
    • Effects of Cherry's Extract on Increased Osteclastogenesis in Obese Children

      hrp0089rfc6.6
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Next Generation Sequencing Results in 142 Patients with Congenital Hyperinsulinism

      hrp0089rfc7.1
    • Outcomes of a Quality Improvement Project Integrating Continuous Glucose Monitoring Systems into the Routine Management of Neonatal Hypoglycaemia

      hrp0089rfc7.2
    • Central Venous Cathether-Associated Thrombosis in Children with Congenital Hyperinsulinism

      hrp0089rfc7.3
    • Expression of MIR-576-5p in Umbilical Cord as a Novel Biomarker for the Identification of Catch-up Growth in Small-For-Gestational-Age Infants

      hrp0089rfc7.4
    • Alteration of Renal Corticosteroid Signaling Pathways in Preterm Infants: Neonatal Adaptation and Developmental Programming of Hypertension

      hrp0089rfc7.5
    • Assessment of Pituitary Stalk Anatomy by T2 DRIVE without Gadolinium in Pituitary Diseases

      hrp0089rfc7.6
  • Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology
  • • Male Fertility Genes Located in Y-Chromosomal Regions Display Differential mRNA Profiles in Response to GnRH Treatment of Cryptorchidism-Dependent Infertility

      hrp0089rfc8.1
    • High Mobility Group Box 1 (HMGB1) is Increased in Adolescents with Polycystic Ovarian Syndrome (PCOS) and Decreases after Treatment with Myo-Inositol in Combination with [alpha]-Lipoic Acid (MYO+ALA)

      hrp0089rfc8.2
    • Pharmacological Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS

      hrp0089rfc8.3
    • Establishing Age, Sex, and Method Related Reference Ranges for Anogenital Distance - a Marker of In Utero Androgen Action

      hrp0089rfc8.4
    • Latest Progress in Tissue Engineered Urethral Regeneration: From Rabbit to Dog, a Step from Human Clinical Trial for Surgical Treatment of VSD (Variation of Sex Development)

      hrp0089rfc8.5
    • Metabolic Profile of Young Adult Transgender Persons Who Started Gender Affirming Treatment in their Adolescence

      hrp0089rfc8.6
  • Pituitary, Neuroendocrinology and Puberty 1
  • • Clinical and Genetic Features of Central Precocious Puberty Associated with Complex Phenotypes

      hrp0089rfc9.1
    • Novel Variant in GNRHR Gene Regulatory Region in a Pedigree with Maternally Inherited Precocious Puberty

      hrp0089rfc9.2
    • What is the Best Parameter to Decide the Initial Dose of Depot Leuprolide Acetate in Girls with Idiopathic Central Precocious Puberty?

      hrp0089rfc9.3
    • REplacement of MAle mini-Puberty in Neonates and Children with Micropenis and Cryptorchidism due to Hypogonadotropic Hypogonadism: Results of the 'REMAP' Study ISRCTN13007297

      hrp0089rfc9.4
    • Non-Isolated Central Precocious Puberty: Prevalence of Brain Lesions and Other Associated Disorders

      hrp0089rfc9.5
    • Can Neuroimaging Predict Endocrine Morbidity in Congenital Hypothalamo-Pituitary (H-P) Disorders?

      hrp0089rfc9.6
  • Late Breaking
  • • Patients with GH Insensitivity and IGF-1 Resistance Harbour Copy Number Variants Causing a Silver-Russell-Like Phenotype

      hrp0089rfc10.1
    • Non-Inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-Releasing Hormone Infusion Therapy in Male Adolescent Patient Withcongenital Hypogonadotropic Hypogonadism

      hrp0089rfc10.2
    • Developmental Regulation of Obestatin and Adropin in Prader-Willi Syndrome and Non-Syndromic Obesity: Associations with Weight, BMI-z, HOMA-IR, and Lipid Profile

      hrp0089rfc10.3
    • Comparative Analysis between Immunoassay and Tandem Mass Spectrometry for Androgens before and after Human Recombinant Gonadotrophin in Children with Genital Ambiguity and 46,XY Karyotype

      hrp0089rfc10.4
    • Abstract unavailable

      hrp0089rfc10.5
    • Effect of the Current Treatment of X-Linked Hypophosphatemia During Growth on the Development of Osteoarticular Lesions in the Hyp Mouse Model

      hrp0089rfc10.6
  • Bone, Growth Plate & Mineral Metabolism 2
  • • Diagnosis and Management of Pseudohypoparathyroidism and Related Disorders: First International Consensus Statement

      hrp0089rfc11.1
    • Nationwide Hypophosphatemic Rickets Study

      hrp0089rfc11.2
    • Increased Levels of Bone Formation and Resorption Markers in Patients with Hypophosphatemic Rickets

      hrp0089rfc11.3
    • A New Form of Anhidrotic Ectodermal Dysplasia with Immunodeficiency Caused By Abolished Store-Operated Ca2+ Entry

      hrp0089rfc11.4
    • The Determinants of Skeletal Fragility in Children with Type 1 Diabetes Mellitus

      hrp0089rfc11.5
    • Reference Values of Automated Bone Age and Bone Health Index for Mexican Children and Adolescents

      hrp0089rfc11.6
  • Diabetes and Insulin 2
  • • Use of Acid-Suppressivemedications During Infancy and Early Childhood and Its Association with Type 1 Diabetes

      hrp0089rfc12.1
    • Bone Mineral Density is Increased in 276 Danish Children and Adolescents with Type-1-Diabetes

      hrp0089rfc12.2
    • Barriers and Sources of Support for the Performance of Physical Activity in Pediatric Type 1 Diabetes

      hrp0089rfc12.3
    • Use of Telemonitoring Via a Mobile Device App Reduces HbA1c in Type 1 Diabetic Children and Adolescents

      hrp0089rfc12.4
    • Insulin Gene Promoter Methylation Status in Greek Children and Adolescents with Type 1 Diabetes

      hrp0089rfc12.5
    • AMGLIDIA, a Suspension of Glibenclamide for Patients with Neonatal Diabetes, Long Term Data on Efficiency and Tolerance

      hrp0089rfc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Risk of Long-Term Endocrine Sequelae in Survivors of Progressing Childhood Optic Pathway Glioma (OPG) Treated by Upfront Chemotherapy: Preliminary Analyses of 102 Subjects from the French Multicentric BB-SFOP Registry

      hrp0089rfc13.1
    • Growth Outcomes and Near Adult Height of Children with Congenital GH Deficiency (GHD) due to Abnormal Pituitary Development: Data from a Prospective, Multinational Observational Study

      hrp0089rfc13.2
    • Circulating MKRN3, Kisspeptin and IGF-1 Levels in Girls During the Clinical Onset of Puberty

      hrp0089rfc13.3
    • Gain in Predicted Adult Height Using the Combination of an LHRH Analogue and an Aromatase Inhibitor in Early Maturing Girls with Compromised Growth for 2 yrs or Until the Age of 11 is Maintained and Further Improved by Aromatase Inhibitor Monotherapy: Results on Final Height of the 'GAIL' Study ISRCTN11469487

      hrp0089rfc13.4
    • Pubertal Voice Break: Temporal Relation of Secondary Sexual Characteristics in Healthy Boys

      hrp0089rfc13.5
    • Close Correlation between Salivary and Blood Steroids in Normal Boys: Salivary Testosterone Best Characterizes Male Puberty

      hrp0089rfc13.6
  • Multisystem Endocrine Disorders
  • • Psychometric and Psycho-social Profile of Children and Adolescent Survivors of Pediatric Cancer

      hrp0089rfc14.1
    • British Society for Paediatric Endocrinology and Diabetes Peer Review of Specialised Paediatric Endocrinology Services in the UK - Evaluation of the Outcomes

      hrp0089rfc14.2
    • Dysregulated Glucose Homeostasis in Congenital Central Hypoventilation Syndrome

      hrp0089rfc14.3
    • A Novel Germline DICER1 Mutation in a Girl with Multinodular Goiter and Ovarian Sertoli-Leydig Cell Tumor

      hrp0089rfc14.4
    • Natural Course of MEN Type 2B Syndrome; a Dutch Single-Center Cohort

      hrp0089rfc14.5
    • Identification of Epithelial Sodium Channel (ENaC) in Endometrial Pipelle Biopsy Samples

      hrp0089rfc14.6
  • Growth and syndromes
  • • Diagnosis of Silver-Russell Syndrome in Patients with Chromosome 14q32.2 Imprinted Region Disruption: Phenotypic and Molecular Analysis

      hrp0089rfc15.1
    • Molecular and Clinical Analyses of Two UPD(16)mat Patients Detected by Screening of 94 Silver-Russell Syndrome Patients without Known Etiology

      hrp0089rfc15.2
    • Multiple Pituitary Hormone Deficiencies and Early Onset Obesity in Two Siblings with a Mutation in the MAGEL2-gene: Evidence for an Important Regulatory Function of the MAGEL2-gene in the Hypothalamic-Pituitary Hormone Pathways

      hrp0089rfc15.3
    • Characteristics, Effectiveness and Safety Data from Clinically Relevant Subgroups of Patients with Severeprimary IGF-I Deficiency (SPIGFD): Results from the European Increlex® Growth Forum Database (EU-IGFD) Registry

      hrp0089rfc15.4
    • Effect of Adjusting for Tanner Stage Age on Short and Tall Stature Prevalence in US Youths

      hrp0089rfc15.5
    • Latest Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment

      hrp0089rfc15.6
• Poster Presentations
• • Adrenals and HPA Axis P1
  • • Evaluation of Long Term Metabolic Effects After Prenatal Dexamethasone Treatment in the Context of CAH - the Swedish Cohort

      hrp0089p1-p001
    • Obesity and Cardio-metabolic Risk Factors among Children and Adolescents with Non-Classic 21-Hydroxylase Deficiency

      hrp0089p1-p002
    • Cognition in Children with Congenital Adrenal Hyperplasia

      hrp0089p1-p003
    • Carriers of CYP21A2 Mutations have Decreased Mortality in Infectious Diseases, Anational Population Registry Study

      hrp0089p1-p004
    • Elevated Concentrations of Adrenal Steroid Precursors with Glucocorticoid Activity Might Prevent Addisonian Crisis in Untreated Patients with Classic Congenital Adrenal Hyperplasia

      hrp0089p1-p005
    • Altered DNA Methylation in Peripheral T-cells from Patients with Congenital Adrenal Hyperplasia

      hrp0089p1-p006
    • Birth Incidence, Age at Diagnosis, Mortality in Congenital Adrenal Hyperplasia in Korea: A Nationwide Population-based Study

      hrp0089p1-p007
    • Impact of Puberty on Final Height in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH)

      hrp0089p1-p008
    • The Relationship of Baseline, Incremental and Peak Cortisol Following a Short Synacthen Test - Single-centre Analysis of Three Years' Data

      hrp0089p1-p009
    • The Circadian Rhythm of Cortisol Binding Globulin has Little Impact on Cortisol Exposure after Hydrocortisone Dosing

      hrp0089p1-p010
    • Characterizing the Steroidome in Ammniotic Fluid of Mid-gestation by LC-MS/MS

      hrp0089p1-p011
    • Pediatric Adrenocortical Tumors. A Single Tertiary Center Experience: Clinical, Biological and Pathologic Characteristics Analysis

      hrp0089p1-p012
    • Role of Mast Cells in the Establishment of the Mineralocorticoid Pathway in the Developing Mouse

      hrp0089p1-p013
    • Molecular Characterization of TNXA/TNXB Chimeras in CYP21A2 Gene Deletions: High Frequency of Undiagnosed Ehlers-Danlos Syndrome in Congenital Adrenal Hyperplasia Patients

      hrp0089p1-p014
    • New Insights into Low Dose Dexamethasone Suppression Test in Paediatric Cushing's Syndrome

      hrp0089p1-p015
    • Recurrent Hypoglycemia in a Preschooler Girl with Overgrowth: Isolated ACTH-Deficiency with a Novel TPIT Mutation

      hrp0089p1-p016
    • Biochemical, Genetic and Molecular Characterization of a Novel P399_E401Dup Mutation in P450 Oxidoreductase (POR) Altering Several Enzymatic Activities in a Patient with a 46,XX DSD Phenotype at Birth

      hrp0089p1-p017
    • Young Lean Women with Evidence of Both Premature Adrenarche and Pubarche Display a Metabolic, Hormonal and Psychologic Profile that is Similar to that of their Peers with Polycystic Ovary Syndrome

      hrp0089p1-p018
    • The Usefulness of Combined Analysis of Serum and Salivary Maximum Cortisol Response to Low-Dose ACTH Test to Define the Requirement of Hormone Replacement Treatment

      hrp0089p1-p019
    • High DHEAS (HD) in Girls Determines Earlier Pubertal Maturation and Mild Hyperandrogenism throughout Pubertal Development

      hrp0089p1-p020
    • Higher Dehydroepiandrosterone Levels in Prepubertal Children Born Very Preterm

      hrp0089p1-p021
    • A Large Consanguineous Family with a Mild and Transient form of Autosomal Recessive Pseudohypoaldosteronism type 1 (PHA1) Caused by a Novel Mutation in the SCNN1A Gene: Functional Studies

      hrp0089p1-p022
    • Associations Between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Pairs of Children 18-48 Months Old and their Mothers With and Without Perinatal Mental Disorders

      hrp0089p1-p023
    • Gonadotropin-Dependent Pubertal Disorders are Common in Patients with Virilizing Adrenocortical Tumors in Childhood

      hrp0089p1-p024
  • Adrenals and HPA Axis P2
  • • Contribution of Direct Measurements of Steroids by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) in Non-classical Adrenal Hyperplasia (NCCAH)

      hrp0089p2-p001
    • GnRH-analogue Treatment in Children with Congenital Adrenal Hyperplasia (CAH): Data from a Multicenter CAH Registry

      hrp0089p2-p002
    • Glucocorticoid Replacement Regimens in the Treatment of 21-hydroxylase Deficiency Congenital Adrenal Hyperplasia: A Systematic Cochrane Review

      hrp0089p2-p003
    • Hydrocortisone (HC) Dose in Children with Congenital Adrenal Hyperplasia (CAH)

      hrp0089p2-p004
    • Perioperative Care of CAH - Incongruencies of Practices among Canadian Specialists

      hrp0089p2-p005
    • Analysis of Phenotypes and Genotypes in 84 Patients with 21-hydroxylase Deficiency

      hrp0089p2-p006
    • Miscarriages in Families with a Child with Classic Congenital Adrenal Hyperplasia and 21-Hydroxylase Deficiency (CAH)

      hrp0089p2-p007
    • Testing Antiandrogens and Aromatase Inhibitors to Achieve Normal Growth in Children with Classical Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis

      hrp0089p2-p008
    • Phenotype-genotype Correlations of CYP21A2 Mutations in Patients with Congenital Adrenal Hyperplasia in Turkey

      hrp0089p2-p009
    • Hypoglycemic Crisis and Salt Loss in Children with Classic Congenital Adrenal Hyperplasia

      hrp0089p2-p010
    • Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38 935 Infants

      hrp0089p2-p011
    • Autoantibodies Against 21-Hydroxylase in Prediction of Adrenal Failure in APECED Patients

      hrp0089p2-p012
    • A First Combination Case of 21-Hydroxilase Deficiency and CHARGE Syndrome Confirmed by Genetic Analysis

      hrp0089p2-p013
    • Frequency of Enzyme Deficiencies in a Turkish Cohort of Congenital Adrenal Hyperplasia: A Single-Center Experience with 145 Patients

      hrp0089p2-p014
    • Study of Cardiovascular Risk Factors and Carotid Intima-Media Thickness in Children with Congenital Adrenal Hyperplasia

      hrp0089p2-p015
    • The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis

      hrp0089p2-p016
    • Childhood Growth Advancement in Girls with Premature Adrenarche Heralds Anabolic Effects by Adulthood

      hrp0089p2-p017
    • A Novel Mutation in the MC2R Gene in a Two-year-old Boy with Adrenal Insufficiency

      hrp0089p2-p018
    • Two Cases of Apparent Mineralocorticoid Excess due to Novel Mutations in HSD11B2 Gene

      hrp0089p2-p019
    • Long-term Follow-up of Safety and Disease Control for Hydrocortisone Granules Designed to give Age-appropriate Dosing with Taste Masking to Children with Adrenal Insufficiency

      hrp0089p2-p020
    • Borderline Peak Plasma Cortisol Following Synacthen Stimulation - Single-centre Analysis of Three Years Data

      hrp0089p2-p021
    • Unilateral Adrenalectomy for Primary Pigmented Nodular Adrenocortical Disease Causing Cushing Syndrome

      hrp0089p2-p022
    • Adrenal Crisis in Children with Adrenal Insufficiency: Prevalence and Risk Factors

      hrp0089p2-p023
    • The Effectiveness of a Stress-Management Intervention Program in Behavioral Parameters and Hair Cortisol Concentrations in Children with Attention Deficit Hyperactivity Disorder

      hrp0089p2-p024
    • Very High Dehydroepiandrosterone Sulfate (DHEAS) in Serum of an Overweight Female Adolescent without a Tumor

      hrp0089p2-p025
    • Early Recognition of Adrenal Insufficiency after Hematopoietic Stem Cell Transplantation During Childhood

      hrp0089p2-p026
    • Reference Values for Serum 17-alfa Hydroxyprogesterone and Adrenal Size in Healthy Newborns

      hrp0089p2-p027
    • A Rare Case of ACTH-Independent Cushing's Syndrome due to Bilateral Micronodular Adrenal Hyperplasia and Myoclonic Dystonia

      hrp0089p2-p028
    • Two Siblins and Three Cousins with Allgrove (4A) Syndrome in a Turkısh Family: A Novel Mutation in the 'Aladin' Gene

      hrp0089p2-p029
    • Ganglioneuroma Presenting as an Adrenal Incidentaloma in a 10-year-old boy-a Rare Entity

      hrp0089p2-p030
    • The Relationship Between Vitamin D Status and Metabolic Abnormalities in Females with Classical Congenital Adrenal Hyperplasia: A Pilot Study

      hrp0089p2-p031
    • Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism

      hrp0089p2-p032
    • Quantitative Ultrasound Evaluation in a Cohort of 43 Young Adults with Classical CAH due to 21-Hydroxylase Deficiency (21OHD): Is Bone Mineral Quality Impaired?

      hrp0089p2-p033
    • Etiology of Primary Adrenal Insufficiency in Children: a 29-year Single Center Experience

      hrp0089p2-p034
    • Pseudopubertas Praecox in a 4 Year Old Boy with Bilateral Atypical Adrenocortical Adenomas

      hrp0089p2-p035
  • Adrenals and HPA Axis P3
  • • Congenital Adrenal Hyperplasia: A Patient's Perspective, a Mother's Story

      hrp0089p3-p001
    • An Extremely Rare Cause of Cushing Syndrome in Chidhood

      hrp0089p3-p002
    • Nelson's Syndrome after Bilateral Adrenalectomy for Cushing's Disease in Pediatric Age - Report of a Case

      hrp0089p3-p003
    • Basal Levels of 17-hydroxyprogesterone can Distinguish Isolated Precocious Pubarche from Non-Classical Congenital Adrenal Hyperplasia in Children: A Prospective Observational study

      hrp0089p3-p004
    • Age at Diagnosis and Outcome in Maghreb patients with 21-hydroxylase Deficient Congenital Adrenal Hyperplasia; Urgent need for Newborn Screening

      hrp0089p3-p005
    • An Adrenal Tumor Ppresenting as a Premature Pubarche in a 7 Year-old Girl

      hrp0089p3-p006
    • Refractory Cyclical Cushing's Disease - a Case of Multiple Pituitary Micro-adenomas in a Three Year Old Girl after 8 Years Follow up

      hrp0089p3-p007
    • Topical Corticosteroid-Induced Adrenal Insufficiency

      hrp0089p3-p008
    • Early Diagnosis of Duchenne Muscular Dystrophy in 6-Months-Old Male with Primary Adrenal Insufficiency

      hrp0089p3-p009
    • Lipoid Adrenal Hyperplasia Diagnosed with Severe Cholestasis in Newborn

      hrp0089p3-p010
    • Severe Hyponatraemia with Absence of Hyperkalaemia in a Patient with Addison's Disease

      hrp0089p3-p011
    • Deep Bronze Skin without Sun Exposition in a 16-Year Old Girl

      hrp0089p3-p012
    • Case of Primary Pigmented Nodular Adrenocortical

      hrp0089p3-p013
    • Two Case Report of Adrenocortical Adenoma

      hrp0089p3-p014
    • A Homozygous Mutation c.518T>A (p.lle173Asn) of the CYP21A2 Gene Presenting as Non-Classical Congenital Adrenal Hyperplasia (NCAH)

      hrp0089p3-p015
    • Adrenals and HPA Axisa; Atypical Presentation of Adrenal Insufficiency

      hrp0089p3-p016
    • Non-classic Congenital Adrenal Hyperplasia Causing Alleles among Adolescent Girls with PCOS - Genetical Study

      hrp0089p3-p017
    • Adequate Interpretation of Cortisol Levels in Children

      hrp0089p3-p018
    • Erythrocytosis as First Manifestation of Adrenal Mass

      hrp0089p3-p019
    • A Neonatal Case with Familial Glucocorticoid Deficiency Type 1 Having Adrenal Crisis in Early Period

      hrp0089p3-p020
    • Presenting Features, Clinical Characteristics and Follow up of Familial Isolated Glucocorticoid Deficiency (FGD) due to Mutations in MC2R and MRAP Genes

      hrp0089p3-p021
    • Identification of X-linked Adrenoleukodystrophy in Boys Presenting with Adrenal Insufficiency in the Absence of Adrenal Antibodies

      hrp0089p3-p022
    • Secondary Hyperaldosteronism in the Course of Cystic Fibrosis

      hrp0089p3-p023
    • The P30L Mutation in the CYP21A2 Gene in a Girl with Congenital Adrenal Hyperplasia with Hidden Salt Loosing and Central Precocious Puberty

      hrp0089p3-p024
    • Congenital Adrenal Hyperplasia due to a Rare Homozygous Mutation R483P in the CYP21A2 Gene and Coexisting Growth Hormone Deficiency

      hrp0089p3-p025
    • Rare Case of Androgen Producing Tumor in 14 Month Old Girl

      hrp0089p3-p026
    • Adrenocortical Tumours in Children - A Case Series

      hrp0089p3-p027
    • Discrete Virilization in Girls with the Classic Form of Congenital Adrenal Hyperplasia: the Importance of a Detailed Genital Examination at Birth

      hrp0089p3-p028
    • A New Methodology for Early Identification of Steroid Resistant Acute Graft-Versus-Host Disease Patients

      hrp0089p3-p029
    • Delayed Diagnosis of a Patient with Antley-Bixler Syndrome

      hrp0089p3-p030
    • Clinical and Biochemical Phenotype of Aldosterone Synthase Deficiency

      hrp0089p3-p404
    • Is the Third Time Really a Charm? The Story about Three Brothers Suffering from Adrenoleukodystrophy and about HSCT being a Chance to Stop the Unstoppable Disease

      hrp0089p3-p414
  • Bone, Growth Plate & Mineral Metabolism P1
  • • Intrauterine Growth Restriction, Antenatal Steroids, Gestational Age and Breast Feeding Influence Bone Health in Prepubertal Children Born Preterm

      hrp0089p1-p025
    • Duration of Breastfeeding and Bone Mineral Density in Childhood - A Prospective Study Among Preschool Children

      hrp0089p1-p026
    • Bone Health in Adolescents Born Small for Gestational Age (SGA)

      hrp0089p1-p027
    • Longitudinal Study of Bone Mass in Swedish Children Treated with Modified Ketogenic Diet

      hrp0089p1-p028
    • Fracture Epidemiology for Children in Western Australia between 2005-2015: Do We Need to be Concerned about Bone Health?

      hrp0089p1-p029
    • Bone Biochemistry in Children with Fractures Presenting with Suspected Non-accidental Injury

      hrp0089p1-p030
    • Systematic Screening Using DXA Lateral Vertebral Morphometry is Associated with a High Prevalence of Vertebral Fractures in Duchenne Muscular Dystrophy: Results from ScOT-DMD Study

      hrp0089p1-p031
    • Bone Mineral Density and Glycemic Control in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0089p1-p032
    • Comparison of Manual and Automated Bone Age Assessment in 1285 Children and Adolescents Aged 5 to 16 Years

      hrp0089p1-p033
    • Is Plasma C-Type Natriuretic Peptide Level Available for Typing and Diagnosis of Skeletal Dysplasia Cases?

      hrp0089p1-p034
    • Long-term Outcomes of Osteogenesis Imperfecta in the Bisphosphonate Era

      hrp0089p1-p035
    • Novel LRP5 Loss-of-function Mutation Causes Osteoporosis-pseudoglioma Syndrome

      hrp0089p1-p036
    • Hypercalcaemia after Treatment with Denosumab in Children: Bisphosphonates as an Option for Therapy and/or Prevention?

      hrp0089p1-p037
    • Disease Burden and Systemic Manifestations of HPP in Children Enrolled in the Global HPP Registry

      hrp0089p1-p038
    • 3-epi-25 Serum 25-hydroxyvitamin D3 Concentrations in Chilean Children between 5 and 8 Years

      hrp0089p1-p039
  • Bone, Growth Plate & Mineral Metabolism P2
  • • Length Estimation Based on Clinical and Anthropometric Measures in Newborns

      hrp0089p2-p036
    • Vitamin D Deficient (Nutritional) Rickets Presenting in Infancy

      hrp0089p2-p037
    • The Effect of Vitamin D Receptor Polymorphism on Bone Mineral Density in Egyptian Patients with Beta Thalassemia Major

      hrp0089p2-p038
    • Vitamin D in Adolescents: A Comprehensive Review of Guidelines and Recommendations

      hrp0089p2-p039
    • X-linked Hypophosphatemia Registry - An International Prospective Patient Registry

      hrp0089p2-p040
    • Clinical and Biological Parameters Associated to the Severity of X-linked Hypophosphatemia in Children

      hrp0089p2-p041
    • High Fibroblast Growth Factor (FGF) 23: An Unusual Cause of Severe Osteoporosis in a Patient with Chronic Liver Disease

      hrp0089p2-p042
    • Metabolic Syndrome in Children with X-linked Hypophosphatemic Rickets (XLHR)

      hrp0089p2-p043
    • High Incidence of Cranial Synostosis and Chiari Malformation in Children with X-linked Hypophosphatemic Rickets

      hrp0089p2-p044
    • An Unusual Case of Hypophosphatemia in a Child Affected by Di George Syndrome

      hrp0089p2-p045
    • Novel SLC34A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia

      hrp0089p2-p046
    • A Novel Variant of SLC34A1 Gene in an Infant with Idiopathic Infantile Hypercalcemia

      hrp0089p2-p047
    • Infantile Arterial Calcification and Subsequent Hypophosphatemia due to ENPP1 Mutation - A Case Followed through to Adulthood

      hrp0089p2-p048
    • Pediatric Quality of Life Inventory in Children with Osteogenesis Imperfect in Dr Soetomo Hospital Surabaya

      hrp0089p2-p049
    • Osteoporosis-pseudoglioma Syndrome (OPPG): Improvement of Osteoporosis on Biphosphonate Therapy

      hrp0089p2-p050
    • Bone Marrow Adiposity and IGF System in Obese Children and Adolescents

      hrp0089p2-p051
    • Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency

      hrp0089p2-p052
    • Follow-up on Bone Health in Children with Acute Lymphoblastic Leukemia (ALL)

      hrp0089p2-p053
    • Effect of Pubertal Inductionn Bone Mass Accrual, in Adolescent Boys with Duchenne Muscular Dystrophy

      hrp0089p2-p054
    • Oxandrolone Improves the Linear Growth and Osteoporosis in Teenage Bays with Osteogenesis Imperfecta

      hrp0089p2-p055
    • First Reported Cases of a Novel Variant of GNAS 1 Gene

      hrp0089p2-p056
    • An Unusual Cause of Short Stature

      hrp0089p2-p057
    • Validation of an Automated Method (BoneXpert) for the Determination of Bone Age in Paediatric Endocrinology - A Single Centre Experience

      hrp0089p2-p058
    • Arthrogryposis Multiplex Congenita Type II and Panhypopituitarism

      hrp0089p2-p059
  • Bone, Growth Plate & Mineral Metabolism P3
  • • Growth Hormone Treatment of 2 Patients with X-linked Hypophosphatemic Rickets Caused by PHEX Mutation: Effects on Linear Growth

      hrp0089p3-p031
    • A Novel Homozygous Mutation in the CASR Gene in a Neonate with Severe Primary Hyperparathyroidism; A Case Report

      hrp0089p3-p032
    • A 13 Year-Old Boy Diagnosed as Osteogenesis Omperfecta with Normal Bone Mineral Density

      hrp0089p3-p033
    • A Rare Cause of Hypercalcemia in Childhood: Hypercalcemia Associated with Parathormon-Related Peptid

      hrp0089p3-p034
    • Our Treatment Experience with Nocturnal Continuous Enteral Calcium Infusion in a Case with Vitamin D Resistance Rickets Type II

      hrp0089p3-p035
    • A Novel COL1A2 Gene Mutation in a Turkish Family with Osteogenesis Imperfecta

      hrp0089p3-p036
    • Hypophosphatemic Hypercalciuric Ricket: 3 Brothers with Dent's Disease

      hrp0089p3-p037
    • Infantile Hypophosphatasia

      hrp0089p3-p038
    • Carbonic Anhydrase Deficiency: Three Siblings

      hrp0089p3-p039
    • A Novel p.Gly775Glu Missense COL1A2 Mutation Causes Severe Osteogenesis Imperfecta in a Prepubertal Girl

      hrp0089p3-p040
    • SHOX Gene Deletion Screening by FISH in Children with Short Stature and Characteristics of Patients

      hrp0089p3-p041
    • Pseudoachondroplasia

      hrp0089p3-p042
    • Low Level of Vitamin D in Children Increases the Risk of Bone Fractures

      hrp0089p3-p043
    • Clinical Evaluation of Eight Patients with Parathyroid Adenoma

      hrp0089p3-p044
    • Idiopathic Hypoparathyroidism in a 10 Year-Old Girl with Concomitant Epilepsy, Long Q-T Syndrome (LQTS), Pericarditis and Pneumonia

      hrp0089p3-p045
    • The Level of the Vitamin D and Bone Mineral Density in Children with Obesity

      hrp0089p3-p046
    • Evaluation of Bone Mineral Density and Bone Metabolism Markers in Children Diagnosed as Celiac Disease

      hrp0089p3-p047
    • Comparison of Serum 25-Hydroxy Vitamin D Levels among Children & Adolescence with Attention Deficit Hyperactivity Disorder and Healthy Lranian People

      hrp0089p3-p048
    • Evaluating the Effect of Zoledronic Acid on Treatment of Primary and Secondary Pediatric Osteoporosis at Children's Hospital 1 in Vietnam

      hrp0089p3-p049
    • Hypocalcemia Secondary to Maternal Vitamin D Deficiency

      hrp0089p3-p050
    • Clinical and Genetic Evaluations of Three Patients with Vitamin D Dependent Rickets Type 1A

      hrp0089p3-p051
    • A Rare Case of Familial Hypocalcemia

      hrp0089p3-p052
    • HDR Syndrome: A Case Report of Hypoparathyroidism, Hearing Loss and Renal Agenesis

      hrp0089p3-p053
    • Growth in The Coeliac Disease of The Child

      hrp0089p3-p054
    • The British OsteoNEcrosis Study: A Multi-centre Prospective Study

      hrp0089p3-p055
    • Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta

      hrp0089p3-p056
    • Results of 22 Weeks of Burosumab Therapy in a Patient with Severe Bone Deformities due to XLH

      hrp0089p3-p057
    • Severe Neonatal Hypercalcemia: A Challenging Case

      hrp0089p3-p058
    • Assessment of Vitamin D Status in Healthy Pre-pubertal Egyptian Children

      hrp0089p3-p059
    • Are Caucasian Children at Risk of Sub-optimal Vitamin D Levels?

      hrp0089p3-p060
    • Incidence Rate of Vitamin D Deficiency in 12-year Old Children in Japan

      hrp0089p3-p061
    • Idiopathic Juvenile Osteoporosis: Common Symptoms in an Uncommon Condition

      hrp0089p3-p062
    • Abstract unavailable

      hrp0089p3-p063
    • Hypercalcemia Associated with Increased Parathyroid Hormone-related Protein (PTHrP) in a Patient with Medulloblastoma Successfully Treated with Pamidronate

      hrp0089p3-p064
    • A Novel Deletion Mutation in the GLUT 2 Gene in a Patient with Fanconi Bickel Syndrome

      hrp0089p3-p065
    • A Case of Turner Syndrome with Graves' Disease and Primary Hyperparathyroidism

      hrp0089p3-p066
    • Neonatal Hypocalcemia Revealing a Malignant Osteopetrosis

      hrp0089p3-p067
    • Frontal Behavior Dysfunctions Revealing a Dramatic Progression of Complex Cranial Base Abnormalities in a Severe Osteogenesis Imperfecta

      hrp0089p3-p068
    • Ionized Calcium and 25-Hydroxyvitamin D3 in Children with Steroid-sensitive Nephrotic Syndrome

      hrp0089p3-p069
    • Hypercalcemia due to Six Newly Identified Inactivating Mutations in the CaSR Gene

      hrp0089p3-p070
  • Diabetes & Insulin P1
  • • Poor Metabolic Control in Children and Adolescents with Type 1 Diabetes and Psychiatric Comorbidity

      hrp0089p1-p040
    • Concealment of Type 1 Diabetes in Adolescence Affects Adherence to Treatment, Metabolic Control, and Quality of Life

      hrp0089p1-p041
    • Risky Behaviors of Adolescents with Type 1 Diabetes in Comparison with their Healthy Peers

      hrp0089p1-p042
    • The Effect of Social Burden on Paediatric Diabetes Outcomes

      hrp0089p1-p043
    • Parental Anxiety about Hypoglycemia of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) and the Associated Factors

      hrp0089p1-p044
    • Management of Diabetes During Ramadan Fasting in Children and Adolescents: Survey of Physicians' Perceptions and Practices in the Arab Society of Paediatric Endocrinology and Diabetes (ASPED) Countries

      hrp0089p1-p045
    • Phenotypes of Diabetes and Determinants of Glycemic Control and Diabetes Complications in Haitian Youth Living in Haiti

      hrp0089p1-p046
    • Smoke Exposure and Cardio-metabolic Profile in Youth with Type 1 Diabetes

      hrp0089p1-p047
    • Menstrual Cycle Disorders in Young Women with Type 1 Diabetes Mellitus

      hrp0089p1-p048
    • Life Changing Decisions due to Etiological Genetic Diagnosis in Families of Children with Maturity Onset Diabetes of the Young (MODY)

      hrp0089p1-p049
    • NBAS Gene Mutation Causes Insulin-Dependent Diabetes Mellitus in a Patient with a Multisystem Disorder Consisting Immunodeficiency and Extremely Short Stature

      hrp0089p1-p050
    • Identification of Six Novel Mutations in Monogenic Diabetes and Congenital Hyperinsulinism and Detected by Targeted-Exome Sequencing in Korea

      hrp0089p1-p051
    • Genetic Susceptibility to Type 1 Diabetes in Children: Analysis of Polymorphisms rs1990760 - IFIH1, rs20541 - IL13, rs231775 - CTLA 4

      hrp0089p1-p052
    • Neonatal Diabetes as a First Symptom of IPEX Syndrom

      hrp0089p1-p053
    • CpG Methylation Status Changes within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes

      hrp0089p1-p054
    • Wolfram Syndrome Case with Hypergonadotropic Hypogonadism: A Novel Mutation

      hrp0089p1-p055
    • Different Clinical Findings in Maturity Onset Diabetes of the Young due to B-Lymphocyte Kinase Gene Mutations

      hrp0089p1-p056
    • Three New Gene Variants (PTPRD, SYT9, and WFS1) Related to Korean MODY Children Decrease Insulin Secretion in Human Pancreatic Beta Cells

      hrp0089p1-p057
    • Comprehensive Genetic Testing Shows One in Five Children with Diabetes and Non-Autoimmune Extra-Pancreatic Features Have Monogenic Aetiology

      hrp0089p1-p058
    • Impact of Diabetes During Pregnancy in Women Affected with GCK-MODY on Neonatal Health Outcome

      hrp0089p1-p059
    • IPEX as a Result of Mutations in FOXP3 Two Case Reports and Review of the Literature

      hrp0089p1-p060
    • The Prevalence of Autonomic and Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetic Mellitus (T1D) and Its Association with the Homozygous Status of Z-2/Z-2 Polymorphism of the Aldose Reductase Gene (AKR1B1) in the Polyol Pathway

      hrp0089p1-p061
    • Establishment of Iron Overload Insulin Cell Model and the Effect Induced by Iron Overload on Oxidative Stress

      hrp0089p1-p062
    • Glucose Intolerance in Survivors of Childhood Hematologic Disorders

      hrp0089p1-p063
    • Efficacy of Mecasermin Treatment and Long-Term Survival in a Child with Leprechaunism

      hrp0089p1-p064
    • Evaluation of Diabetes Related Complications and Endothelial Dysfunction in Adolescents with Type 1 Diabetes

      hrp0089p1-p065
    • Complexities in the Management of New-Onset Diabetes after Transplantation (Nodat) in an Adolescent with Senior-Loken Syndrome

      hrp0089p1-p066
    • Insulin Resistance Parameters in Children Who Were Born Very Preterm and Adequate for Gestational Age

      hrp0089p1-p067
    • Impact on Final Height of Functional Insulin-Therapy in Type 1 Diabetes Mellitus Pediatric Patients - Experience from a Portuguese Pediatric Endocrinology Unit

      hrp0089p1-p068
    • Triglyceride Glucose Index as a Predictor of Impaired Glucose Tolerance in Overweight and Obese Adolescents

      hrp0089p1-p069
    • Birth Weight in Offsprings of Mothers with Gestational Diabetes Mellitus due to Mutations in GCK Gene

      hrp0089p1-p070
    • Review and Audit of Diabetes Control in Children and Young People with Diabetes Using the FreestyleLibre Flash Glucose Scanning System (FGS)

      hrp0089p1-p071
    • Increasing Use of Continuous Glucose Monitoring (CGM) Among Youth with Type 1 Diabetes (T1D): Icomparison of Youth from the T1D Exchange (T1DX) and the DPV Initiative

      hrp0089p1-p072
    • Efficacy of Real-time Continuous Glucose Monitoring in Type 1 Diabetic Pre-school and School Children Treated with Multiple Daily Injections

      hrp0089p1-p073
    • Catheter Site Selection and Anthropometric Measurements at Subjects with Type 1 Diabetes and Continuous Subcutaneous Insulin Infusion

      hrp0089p1-p074
    • Open Source Artificial Pancreas Systems Used from Bulgarian Children and Young People with Diabetes

      hrp0089p1-p075
    • National Survey of Usage of Continuous Glucose Monitoring in Children and Adolescents at Non Reimbursed Setting

      hrp0089p1-p076
    • Additional Insulin is Necessary to Prevent Rise in Blood Glucose after Fat-protein-rich Meals in Type 1 Diabetes

      hrp0089p1-p077
    • Efficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetesefficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetes

      hrp0089p1-p078
    • A Novel SLCA16A1 Mutation in an Infant with Hypoglycemia and Severe Metabolic Ketoacidosis

      hrp0089p1-p079
    • Successful Transition to Sulfonylurea Therapy in Infant with Neonatal Diabetes, Developmental Delay, Epilepsy (DEND Syndrome) due to F132L ABCC8 Mutation

      hrp0089p1-p080
    • ZFP57-associated Transient Neonatal Diabetes is Responsive to Oral Sulfonylurea Treatment

      hrp0089p1-p081
    • The Comparison of the Occurrence of Beta Cells Autoantibody and Regulatory T Cells (CD4+CD25+FoxP3+) in Patients with Type 1 Diabetes Mellitus, their Siblings and Healthy Children

      hrp0089p1-p082
    • HERV-W-Env Protein Expression in Pediatric Type 1 Diabetes Patients

      hrp0089p1-p083
    • The Comparison of the Occurrence of Beta Cells Autoantibody and Natural Killer Cells in Patients with Type 1 Diabetes Mellitus, Their Siblings and Healthy Children

      hrp0089p1-p084
    • T- and B-Lymphocytes Levels in Children with Type 1 Diabetes in Association with Candida Infection

      hrp0089p1-p085
    • Coincidence of Newly Diagnosed Type 1 Diabetes Mellitus with Enteroviruses and Respiratory Tract Viruses

      hrp0089p1-p086
    • Investigation into [beta]-cell Adaptation During Puberty

      hrp0089p1-p087
    • The Shape of the Glucose Curve and Time to Glucose Peak During an Oral Glucose Tolerance Test as Indicators of Beta Cell Function in Obese Adolescents

      hrp0089p1-p088
    • Features of T2DM in Adolescents with Low Titer of ICA and IAA

      hrp0089p1-p089
    • Increasing Trend of Fasting Plasma Glucose Levels and Impaired Fasting Glucose in Non-Diabetic Korean Youth and Young Adults: A Nationally Representative Population-Based Study

      hrp0089p1-p090
    • Screening for T2D in High Risk Egyptian Children and Adolescents Using Strip HbA1c and OGTT

      hrp0089p1-p091
    • Association of the Sizes and Composition of HDL with Hepatic Steatosis in Adolescents with Type 2 Diabetes (T2D)

      hrp0089p1-p092
  • Diabetes & Insulin P2
  • • Incidence of Childhood Type 1 and Type 2 Diabetes Mellitus in Qatar between 2012-2016

      hrp0089p2-p060
    • The Prevalence of Double Diabetes in Children and Adolescents in Qatar

      hrp0089p2-p061
    • Prevalence of Diabetes Type 1 and Type 2 in Children and Adults in Kazakhstan in 2016

      hrp0089p2-p062
    • Detection of the Pathogenic Genes in the Diagnosis and Treatment of Hyperglycemia Infants and Children

      hrp0089p2-p063
    • Early Diagnosis of Diabetes Type 2 in Children with Progeria Syndromes

      hrp0089p2-p064
    • Transient Neonatal Diabetes Mellitus due to not Described Mutation in ABCC8 Gene with Different Behaviour in Affected Family Members

      hrp0089p2-p065
    • Prothrombin Gene 20210A Mutation Heterozygosity and MTHFR Gene C677T Mutation Homozygosity Detected in a Male Toddler Experiencing Femoral Venous Thrombosis During Diabetic Ketoacidosis

      hrp0089p2-p066
    • Frequency of Occurrence of MODY in the Population of Diabetic Patients in St. Petersburg

      hrp0089p2-p067
    • Acute Painful Diabetic Neuropathy (Apdn) in a Boy with Type 1 Diabetes

      hrp0089p2-p068
    • Features of Japanese Patients with Early-Onset, Mody-Like Diabetes without Mutations in the Major Mody Genes

      hrp0089p2-p069
    • Frequency and Etiologic Spectrum of Monogenic Diabetes in Pediatric Diabetes in a Single Academic Center

      hrp0089p2-p070
    • Clinical Details, Molecular Genetic Analysisand Clinical Pheonotype Correlation of 14 Patients with Neonatal Diabetes from The South India - A Single Centre Experience

      hrp0089p2-p071
    • Syndromic Patients with Negative Islet Autoantibodies should be Tested for Mongenic Diabetes: Lessons from Patient with Trmt10a Mutation

      hrp0089p2-p072
    • A Novel Mutation in Phka2: Idiopathic Ketotic Hypoglycaemia May Represent Mild Gsdixa

      hrp0089p2-p073
    • The Application of Next Generation Sequencing Mody Gene Panel in Greek Patients

      hrp0089p2-p074
    • Type 5 Monogenic Diabetes: Reportof 7 Cases

      hrp0089p2-p075
    • Novel Gata6-Mutation in a Boy with Neonatal Diabetes and Diaphragmatic Hernia

      hrp0089p2-p076
    • Clinical and Genetic Characterizations of Maturity Onset Diabetes of the Young: Single Center Results

      hrp0089p2-p077
    • Protein and Fat Effects on Post - Prandial Glucose Responses among Egyptian Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0089p2-p078
    • Amino Acids Plasma Profile in Children with Type 1 Diabetes

      hrp0089p2-p079
    • Betatrophin as a New Biomarker of Type 1 Diabetes Mellitus in Paediatrics

      hrp0089p2-p080
    • Vitamin D Status among Children and Adolescent with T1DM

      hrp0089p2-p081
    • IGF-1 Relationship with Growth Velocity in Precocious Puberty with GnRHa Treatment

      hrp0089p2-p082
    • Relation between Hypomagnesemia and Increased Level of HbA1c in Patients with Diabetes Mellitus

      hrp0089p2-p083
    • PID1 Alters Antilipolytic Action of Insulin and Increases Lipolysis via Inhibited the Activation of AKT/PKA Pathway

      hrp0089p2-p084
    • The Efficacy of Tri-ponderal Mass Index and Body Mass Index in Estimating Insulin Resistance, Hyperlipidemia and Impaired Liver Enzymes During Childhood and Adolescents

      hrp0089p2-p085
    • Local Experience of Diabetes and Deafness

      hrp0089p2-p086
    • Translating the A1C Assay into Estimated Average Glucose Values in Children with Type 1 Diabetes Mellitus

      hrp0089p2-p087
    • Relationship Between Residual Endogenous Insulin Secretion and Glycemic Control in Japanese Children and Adolescents with Type 1 Diabetes

      hrp0089p2-p088
    • A Curious Case of Persistent Lactic Acidosis in a Child with Diabetic Ketoacidosis

      hrp0089p2-p089
    • An Unusual Case of an Exclusively Vegan Child with Diabetic Acidosis

      hrp0089p2-p090
    • HLA-DQ Genotyping in Patients with Type 1 Diabetes Mellitus and Celiac Disease

      hrp0089p2-p091
    • Hypertriglyceridemia in Type 1 Diabetes Children During Diabetic Ketoacidosis; Relation to DKA Severity and Glycemic Control

      hrp0089p2-p092
    • Acute Mononeuropathy in an 8-Year-Old-Girl with Newly Diagnosed Type 1 Diabetes

      hrp0089p2-p093
    • HLA-G Gene Promoter Methylation Status in Children and Adolescents with Type 1 Diabetes

      hrp0089p2-p094
    • Impaired Adrenal Function in Pediatric Patients with Diabetes Mellitus Type 1 Evaluated with Low-Dose Synacthen Test

      hrp0089p2-p095
    • The Incorporation of Available Technologies for Diabetes Care Among Different Worldwide Centers: The ESPE/ISPAD Working Group on Diabetes Technology Survey

      hrp0089p2-p096
    • Higher Percentage of Insulin Pump Users at Isle of Man (IOM) - Two Years Observational Data

      hrp0089p2-p097
    • Use of Continuous Glucose Monitoring Systems in the Early Detection And Management of Cystic Fibrosis Related Diabetes in Children

      hrp0089p2-p098
    • Metabolic Improvement Offered by Medtronic Minimed 640 G Associated to Transient Insulin Perfusion Suspension before Hypoglycemia in Young Patients with Type 1 Diabetes

      hrp0089p2-p099
    • The Glycemic Variability in Children with Diabetes Mellitus

      hrp0089p2-p100
    • The Levels of Blood Glucose and Counting of Carbohydrate-Fat-Protein in Diabetic Children Using Pump with Aspart and Glulisine

      hrp0089p2-p101
    • A Novel Missense Variant, p.(Thr405Arg), in the SLC19A2 Gene in an Infant with Thiamine Responsive Megaloblastic Anemia Syndrome Presenting with Anemia and Diabetes but with Normal Hearing

      hrp0089p2-p102
    • Donohue Syndrome with Hypertrophic Cardiomyopathy

      hrp0089p2-p103
    • Age and Exocrine Pancreatic Enzyme Requirements are Major Determinants for Carbohydrate Metabolism Impairment in Children Affected with Cystic Fibrosis

      hrp0089p2-p104
    • Post-Prandial Hyperinsulinaemic Hypoglycaemia after Oesophageal Surgery in Children

      hrp0089p2-p105
    • Congenital Hyperinsulinism: Clinical and Molecular Characteristics - Fluorine-18-L-Dihydroxyphenylalanine Positron Emission Tomography (F-DOPA PET) Scan Results - Treatment Responses and Short Term Outcomes of 5 Patients

      hrp0089p2-p106
    • Congenital Hyperinsulinism in a Child with Alagille Syndrome

      hrp0089p2-p107
    • Severe Stress-Induced Subcutaneous and Intravenous Insulin Resistance in an Eight Year Old Boy with T1DM, Necessitating Seven Months of IV Insulin, Reversed after Psychiatric Treatment

      hrp0089p2-p108
    • A Case of Neonatal Diabetes Due to Pancreatic Hypoplasia

      hrp0089p2-p109
    • Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins

      hrp0089p2-p110
    • Permanent Neonatal Diabetes, Hepatic Failure and Progressive Left Hemispheric Cerebral Atrophy in a Patient with Wolcott-Rallison Syndrome: A Clinical and Genetic Study from the State of Qatar

      hrp0089p2-p111
    • A Rare Case of Diabetes Mellitus Type 1 in a Child with Neurofibromatosis Type 1

      hrp0089p2-p112
    • Detection and Analysis of Glycometabolism Related Genes in Children Diabetes

      hrp0089p2-p113
    • Gender Characteristics of Responsibility for Their Own Health of Adolescents with Type I Diabetes Mellitus

      hrp0089p2-p114
    • Favorable Outcome Despite Prolonged Hypoglycemic Episodes Following a Massive Insulin Overdose: A Case Series

      hrp0089p2-p115
    • Effect of a Reduced Fluid Replacement Regimen on the Resolution of Diabetic Ketoacidosis (DKA) in Children

      hrp0089p2-p116
    • Prevalence of and Risk Factors for Nonadherence to Insulin Among Paediatric Type 1 Diabetes Patients in Singapore

      hrp0089p2-p117
    • [ldquo]What do You Know About Your Diabetes?': A Qualitative and Quantitative Study of Teenagers and Young Adults' Understanding of their Disease

      hrp0089p2-p118
    • Parental Knowledge and Attitudes Toward Diabetes Mellitus Type 1: A Cross Sectional Study

      hrp0089p2-p119
    • Identifying the Association of Depression and Diabetic Distress in Pakistani Patients Diagnosed with Type 1 Diabetes

      hrp0089p2-p120
    • Role of Breastfeeding in Prevention of Type 1 Diabetes in Pakistan

      hrp0089p2-p121
    • A Young Type 1 Diabetic with Acute Hemichorea: Rare Central Nervous System Complications

      hrp0089p2-p122
  • Diabetes & Insulin P3
  • • Multiple Autoimmune Association and Varied Spectrum of Presentation in Indian Diabetic Children

      hrp0089p3-p071
    • Severe Hypertriglyceridemia and Multiple Autoimmune Phenomenon at new onset Type 1 DM

      hrp0089p3-p072
    • Effects of Diabetes Mellitus Type-1 on Vitamin D Status Among Children

      hrp0089p3-p073
    • Association between Prior Toxic Stressors and Development of T2DM in Adolescents

      hrp0089p3-p074
    • First Four Cases of Neonatal Diabetes from Kazakhstan, Almaty with Proven Mutations in KCNJ11 and INS Genes

      hrp0089p3-p075
    • First 2 Cases of Monogenic Diabetes (MODY) from Kazakhstan, Almaty with Proven Heterozygous Mutation in Hepatocyte Nuclear Factor 1-Alpha (HNF1A) Gene

      hrp0089p3-p076
    • Achievement of Therapy Targets in Children and Adolescents with Type 1 Diabetes Mellitus at the 'Diabetes School'

      hrp0089p3-p077
    • Characteristics of MODY-GCK Diabetes in Children and Adolescents in Siberia

      hrp0089p3-p078
    • Clinical Case of MODY-GCK Diabetes: Heterogeneity of Course among Relatives from One Family

      hrp0089p3-p079
    • Clinical and Biochemical Characteristics of Familial Type 1 Diabetes Mellitus (FT1DM) Compared to Non-Familial Type 1 DM (T1DM)

      hrp0089p3-p080
    • Prevalence of Beta-cell Antibodies and Associated Autoimmune Diseases in Children and Adolescents with Type 1 (T1DM) vs Type 2 Diabetes Mellitus (T2DM) in Qatar

      hrp0089p3-p081
    • Clinical Presentation and Autoimmune Markers in Children and Adolescents with Familial Type 1 Diabetes Mellitus (FT1DM) and Familial Type 2 Diabetes Mellitus (FT2DM)

      hrp0089p3-p082
    • Real-world Clinical Evolution of Type 1 Diabetes Patients on Twenty Years

      hrp0089p3-p083
    • Diabetic Capilaropathy: A Case Report

      hrp0089p3-p084
    • A Sibling Case of Wolfram Syndrome with Diabetes Mellitus Diagnosed within 10 Months in Early Childhood

      hrp0089p3-p085
    • Continuous Subcutaneous Insulin Infusion in Children and Adolescents: Analysis of Initial and Follow Up Basal Rates

      hrp0089p3-p086
    • Prevalance of Fatty Liver in Patients with Type 1 Diabetes Mellitus Attending Diabetes Clinic at Alexandria University Children's Hospital

      hrp0089p3-p087
    • The Triad of Obesity, Acanthosis Nigricans and Diabetes Mellitus in a Newly Diagnosed Adolescent; Is This Type 1 Or Type 2 Diabetes Mellitus?

      hrp0089p3-p088
    • A Female Patient with Atypical Diabetes Features, Showing Heterozygous Mutations on G6PC2 (Glucose 6 Phosphatase, Catalytic Subunit 2): Does Explain All Clinical Manifestations or Is It Only Polymorphism?

      hrp0089p3-p089
    • Clinical and Laboratory Features at the Onset of Childhood Type 1 Diabetes Mellitus in the Nortwest Region (Trakya) of Turkey

      hrp0089p3-p090
    • Clinical and Epidemiological Features of Children with Type 1 Diabetes

      hrp0089p3-p091
    • Predictors of Optimal Glycemic Control in Children with Diabetes Mellitus Type 1 Receiving Pump Insulin Therapy

      hrp0089p3-p092
    • Symptomatic Cerebral Infarction: A Rare Complication of Diabetic Ketoacidosis

      hrp0089p3-p093
    • Our Clinical Experiences in Type 2 Diabetes

      hrp0089p3-p094
    • The Relationship between Serum Levels of C-Peptide and the Age, BMI, and Insulin Doses in Reply to: Newly Diagnosed Type 1 Diabetic Children

      hrp0089p3-p095
    • Serum Trace Element Levels in Children Presenting with Diabetic Ketozis and Diabetic Ketoacidosis: A Longitudinal Controlled Study

      hrp0089p3-p096
    • Evaluation of Relation between Diabetic Education Levels of Type 1 DM Child/Adolescent and Parents and Metabolic Control

      hrp0089p3-p097
    • A Case of Childhood Type 1 Diabetes Mellitus Who Developed Granuloma Annulare

      hrp0089p3-p098
    • Case Report: De Novo Mutation of Foxp3 Causing Mild Phenotype of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Link Syndrome

      hrp0089p3-p099
    • Is There a Relationship between Immune-Mediated Type 1 Diabetes Mellitus and Congenital Rubella Infection?

      hrp0089p3-p100
    • Changes in Glycemic Control after Switching from NPH & RI to Insulin Glargine and Lispro in Children with Type 1 Diabetes Mellitus (T1DM)

      hrp0089p3-p101
    • When Type Mody Ii Diabetes Simulates Type I Diabetes

      hrp0089p3-p102
    • Epidemiological Study and Analysis of Type 1 Diabetes Comparing Patients with and Without Ketoacidosis in the Last 5 Years

      hrp0089p3-p103
    • The Frequency of Diabetic Ketoacidosis Hospitalization in Siberian Children and Adolescent

      hrp0089p3-p104
    • Monogenic Diabetes Cause by Mutation of the Gene HNF-1A

      hrp0089p3-p105
    • Reversibility of Early Acute Diabetic Neuropathy (DN) in Adolescents with Type 1 Diabetes Mellitus (T1D)

      hrp0089p3-p106
    • The Value of Continuous Hemodiafiltration in Rescuing Children with Severe Diabetic Ketoacidosis

      hrp0089p3-p107
    • Psychosocial Risks, Comorbidities and Health Events During the Follow-up of Children and Adolescents with Type 1 Diabetes

      hrp0089p3-p108
    • Clinical Profile and Outcome of Diabetic Ketoacidosis in a Tertiary Care Teaching Hospital of a Developing Country

      hrp0089p3-p109
    • Diabetes Mellitus, Autoimmune Hemolytic Anemia, Hepatosplenomegaly and Lymphadenopathy: A Rare Association in Chinese Children

      hrp0089p3-p110
    • Type 1 Diabetes and Central Precocious Puberty a Rare Association

      hrp0089p3-p111
    • Diabetic Ketoacidosis among Egyptian Children with Type 1 Diabetes: 3-Years Study

      hrp0089p3-p112
    • Fructosamine Level in Type 1 Diabetes Mellitus Children Performing Ramadhan Fasting

      hrp0089p3-p113
    • Metformin Therapy Ina Lean Adolescent Girl with Prediabetes Dysglycemia Treated: Good Response

      hrp0089p3-p114
    • Association between Thyroid Stimulating Hormone and Hemoglobine A1c in Type 1 Diabetes Mellitus Children

      hrp0089p3-p115
    • Monogenic Diabetes in 2 Years and 4 Months Old Girl: Is it DEND?

      hrp0089p3-p116
    • Compliance for Monitoring of Glycemic Control in Children with Type 1 Diabetes

      hrp0089p3-p117
    • Ketogenic Diet in a Child with Diabetes and Global Developmental Delay

      hrp0089p3-p118
    • A Rare Cause of Severe Anemia in a Patient with Type 1 Diabetes

      hrp0089p3-p119
    • Oral Gliclazide (A Sulfonylurea) Monotherapy is Effective and Safe in the Management of T2DM in Children: A Case Report

      hrp0089p3-p120
    • Pediatric Stroke as the Presenting Symptom of New Onset Diabetes without DKA

      hrp0089p3-p121
    • Challenges in Educating New Onset Type 1 Diabetes Mellitus Patients: Can the Use of a Tablet be the Answer?

      hrp0089p3-p122
    • AID-GM System (Advanced Intelligent Distant - Glucose Monitoring) to Monitor Health Status and Metabolic Control of Young People with Type 1 Diabetes

      hrp0089p3-p123
    • Continuous Glucose Monitoring Results of Our Cases with MODY Type 2 Diabetes

      hrp0089p3-p124
    • Family Investigation and Clinical Phenotype Analysis of Type A Insulin Resistance Syndrome

      hrp0089p3-p399
    • Epidemiology, Demographic Criteria and Risk Factors in Type 1 DM Egyptian Children; A Single Center Study

      hrp0089p3-p403
    • Degludec Versus Glargine in Pediatric and Adolescent Patients with Type 1 Diabetes

      hrp0089p3-p407
    • A Rare and Unexpected Cause of Diabetes in Childhood

      hrp0089p3-p416
    • Study of Children with Type 1 Diabetes Mellitus of Long Duration Attending Alexandria University Children'S Hospital

      hrp0089p3-p417
    • Abstract unavailable

      hrp0089p3-p419
  • Fat, Metabolism and Obesity P1
  • • Functional Characterization of Novel and Known Genetic Variants in the Leptin Receptor (LEPR) Gene of Two Patients with Morbid Obesity

      hrp0089p1-p093
    • Association of Single Nucleotide Polymorphisms in TNFA, PNPLA3, ADIPOQ and APOC3 Genes with Obesity and Non-Alcoholic Fatty Liver Disease in North Indian Adolescents

      hrp0089p1-p094
    • Variation of Circulating Brain-Derived Neurotrophic Factor According to Gender, Body Mass Index and Metabolic Syndrome Parameters in Adolescents

      hrp0089p1-p095
    • Kisspeptin and the Genetic Obesidome

      hrp0089p1-p096
    • Circulating Exosomal miRNAs Involved in the Pathogenesis of Children Nonalcoholic Steatohepatitis

      hrp0089p1-p097
    • Placental Fatty Acid Profile, DNA Methylation and Adverse Metabolic Outcomes in the Offspring at School Age

      hrp0089p1-p098
    • Association of Serum Fibroblast Growth Factor 21 and Irisin with Insulin Sensitivity Markers and Serum Lipids in 12-year-old Children

      hrp0089p1-p099
    • Serum Catestatin Levels in Obese Children and Adolescents

      hrp0089p1-p100
    • Circulating Mots-C Levels are Decreased in Obese Male Children and Adolescents and Associated with Insulin Resistance

      hrp0089p1-p101
    • Plasma Adropin Levels are Associated with Lipid Characteristics Amongst Children with Obesity

      hrp0089p1-p102
    • Associations of Non-High-Density Lipoprotein Cholesterol with Metabolic Syndrome and Its Components in Korean Children and Adolescents: the Korea National Health and Nutrition Examination Surveys 2008-2014

      hrp0089p1-p103
    • Chromosomal Deletions at Chromosome 16p11.2 Associated with Severe Early-Onset Obesity- 3 Additional Patients

      hrp0089p1-p104
    • Effect of a Melanocortin-4 Receptor (MC4R) Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Alstrom Syndrome

      hrp0089p1-p105
    • Towards a Greater Understanding of the Pathophysiology of Obesity: Hypothalamic Obesity as a Model of Dysregulation of Appetite and Metabolic Homeostasis

      hrp0089p1-p106
    • Serum Uric Acid Level and Its Association with Metabolic Syndrome in Korean Adolescents

      hrp0089p1-p107
    • More than A Gut Feeling: Preliminary Evidence Supporting a Role for Lifestyle Habits in Shaping the Intestinal Microbiota in Childhood and Adolescence

      hrp0089p1-p108
    • Efficiency of Alpha-lipoic Acid in Metabolic Syndrometreatment in Children

      hrp0089p1-p109
    • Lipid Accumulation Product is a Predictor of Non-alcoholic Fatty Liver Disease in Childhood Obesity

      hrp0089p1-p110
    • Selected Serum Adipokines in Children with Irritable Bowel Syndrome

      hrp0089p1-p111
    • Role of Urinary NGAL and KIM-1 as Early Kidney Injury Biomarkers in Obese Prepubertal Children

      hrp0089p1-p112
    • Maternal Resveratrol Intake During Pregnancy and Lactation Modulates the Long-term Metabolic Effects of Maternal Nutrition on Offspring Depending on the Sex and Diet

      hrp0089p1-p113
    • Intrauterine Metformin Exposure and Offspring Metabolic Health at 8-Years Follow-up

      hrp0089p1-p114
    • Greater Maternal BMI Early in Pregnancy and Excessive Gestational Weight Gain are Independently Associated with Adverse Health Outcomes in the Offspring at Age 7 Years

      hrp0089p1-p115
    • Rapid BMI Gain During Later Infant Accelerates Skeletal Maturation at Prepubertal Obese Children

      hrp0089p1-p116
    • The More Obese - The Less Pubertal Height Gain

      hrp0089p1-p117
    • Longitudinal Changes in Abdominal Fat Distribution in the First Two Years of Life

      hrp0089p1-p118
    • Telemedicine Therapy for Overweight Adolescents: First Results of a Novel Smartphone App Intervention Using a Behavioural Health Platform

      hrp0089p1-p119
    • Cardiorespiratory Fitness Effectiveness is Related to Abdominal Adiposity and Insulin Sensitivity in Overweight Adolescents

      hrp0089p1-p120
    • Promoting Healthy Lifestyles in Youth: Preliminary from the CIRCUIT Program

      hrp0089p1-p121
    • Determinants of Attrition from a Healthy Lifestyle Intervention: Experience from the CIRCUIT Program

      hrp0089p1-p122
    • Interleukin-6 Levels are Associated with High Blood Pressure and Low HDL Cholesterol in Healthy 4-year-old Children

      hrp0089p1-p123
    • Metabolic Phenotype of Human Adipocytes Overexpressing UCP1

      hrp0089p1-p124
    • M2 Macrophage Markers are Enriched in Human Deep Neck Adipose Tissue and Do Not Correlate with UCP1 Expression

      hrp0089p1-p125
    • Effect of Hormonal Changes on Exocrine Pancreatic Function in Girls with Anorexia Nervosa

      hrp0089p1-p126
    • PCSK9 and Lp(a) Levels of Children Born after Assisted Reproduction Technologies

      hrp0089p1-p127
    • Rate of Accumulation of Abdominal Fat is Associated with Fasting Glucose Levels in Early Childhood

      hrp0089p1-p128
    • Early Menarche is Associated with Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Obese Adolescents

      hrp0089p1-p129
    • The Frequency of Obstructive Sleep Apnea in Children with Hypothalamic and Exogenous Obesity

      hrp0089p1-p130
    • The Importance of Universal Lipid Profile Screening in Two to Ten Years Old Lebanese Children

      hrp0089p1-p131
    • Non-Invasive Measurements of Central Blood Pressure with Arterial Stiffness Indicators as a New Research Tool for Predicting Cardiovascular Risk in Children with Type 1 Diabetes Mellitus and Obesity

      hrp0089p1-p132
    • Severe Obesity and Cardiometabolic Comorbidities in Adolescents: Chronology of an Epidemic

      hrp0089p1-p133
    • Evaluation of Intraocular Pressure and Retinal Nerve Fiber Layer, Retinal Ganglion Cell, Central Macular Thickness and Choroidal Thickness Using Optical Coherence Tomography in Obese Children and Healthy Controls

      hrp0089p1-p134
  • Fat, Metabolism and Obesity P2
  • • Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats

      hrp0089p2-p123
    • Relationships of Dietary Intake and Sugar Rich Products Consumption with Hepatic Fat Content and Insulin Resistance among Children with Overweight/Obesity: The PREDIKID Study

      hrp0089p2-p124
    • Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Obese Children and Adolescents: Relation to Hypertension Risk

      hrp0089p2-p125
    • Serum Calprotectin Level in Children: Marker of Obesity and Its Metabolic Complications

      hrp0089p2-p126
    • Pediatric Continuous Metabolic Syndrome Score (PsiMS score): Use in Everyday Clinical Practice

      hrp0089p2-p127
    • Leptin and Cytokines are Not the Best Markers for Metabolic S

      hrp0089p2-p128
    • Early-Life Risk Factors and Their Association with Hypertension in Spanish Children and Adolescents

      hrp0089p2-p129
    • A Rare Case of Diabetes Mellitus in an Adolescent: Partial Lipodystrophy

      hrp0089p2-p130
    • Visfatin, RBP4 and STRA6 polymorphisms' in relation with Childhood Obesity

      hrp0089p2-p131
    • Characteristics of Blood Lipids in Boys with Hypoandrogenia

      hrp0089p2-p132
    • Tri-Ponderal Mass Index: A Good Anthropometric Index to Evaluate Adiposity in Children and Adolescents

      hrp0089p2-p133
    • Serum Spexin Concentrations in Adolescent Females with Metabolic Syndrome, Polycystic Ovary Syndrome and Anorexia Nervosa

      hrp0089p2-p134
    • A Simple Relaxation Exercise Reduces Stress in Obese Youth - A Path to a Healthy Lifestyle?

      hrp0089p2-p135
    • Dyslipidemia and Its Related Factors in Chinese Children and Adolescents with Turner Syndrome

      hrp0089p2-p136
    • Severity, Duration and Phenotype of Obesity Promote Precocious Cardiovascular Sonographic Alterations in Childhood Obesity

      hrp0089p2-p137
    • Physical Activity Determined by Accelerometry Before and After an Integral Treatment Program in Children with Abdominal Obesity

      hrp0089p2-p138
    • The Associations Between Neck - and Upper Arm Circumference with Cardiometabolic Risk Over Traditional Risk Factors in Adolescents - Data from Five EUROPEAN Countries (PreSTART-Study)

      hrp0089p2-p139
    • Sex-related Differences and Effect of Puberty on Metabolic Syndrome in Obese Children and Adolescents

      hrp0089p2-p140
    • Associations between Total Leptin, Bio-inactive Leptin, Soluble Leptin Receptor and Anthropometrics in Children with Severe Early-onset Obesity (SEOO) - the German-Polish Study (EOL-GPS)

      hrp0089p2-p141
    • Children with Obesity are Taller in Early Childhood with Subsequent Catch-down Growth Until Adolescence

      hrp0089p2-p142
    • The Relationship between Anthropometric Measurements and Breast Milk Ghrelin and Nesfatin-1 Levels in Infants with Small for Gestational Age

      hrp0089p2-p143
    • Efficacy, Safety and Tolerability of Liraglutide, GLP-1 Analogue, in Indian Adolescent Population with Obesity

      hrp0089p2-p144
    • The Effect of Exclusive Breastfeeding and Formula Feeding on Body Composition During the First Two Years of Life

      hrp0089p2-p145
    • Body Composition and Cardiovascular Function in Pre-adolescent Children of South Asian and White European Origin: Relationship to Maternal Status in Pregnancy

      hrp0089p2-p146
    • Relation Between Cardiac Function and Anthropometric Parameters in Overweight and Obese School Boys

      hrp0089p2-p147
    • Evaluation of Hydration Status of Obese Children - A Pilot Study

      hrp0089p2-p148
    • Galanin is Positively Correlated with Insulin Resistance and Triglyceride Levels in Obese Children

      hrp0089p2-p149
    • Brown Adipose Tissue in Prepubertal Children: Associations with Sex and With the Sequence of Prenatal Growth Restraint and Postnatal Catch-up

      hrp0089p2-p150
    • The Age of Pubertal Onset Correlates with Pubertal Growth Pattern and Body Weight Change in Girls

      hrp0089p2-p151
    • Does Late Sleeping Time Results Increased Bedtime Snack? What is the Risk of this in Childhood Obesity?

      hrp0089p2-p152
    • Early BMI Trajectory Classes are Linked to Distinct Body Fat Partitioning Later in Childhood

      hrp0089p2-p153
    • Hair Cortisol Concentrations in Overweight and Obese Children and Adolescents

      hrp0089p2-p154
    • Associations between Body Fat Mass and Internalizing and Externalizing Behaviors and Anxiety in Children and Adolescents

      hrp0089p2-p155
    • Pharmacotherapy and the Effects on LDL Levels and Growth in 2 Children with Severe Familial Hypercholesterolemia

      hrp0089p2-p156
    • Brown Tumors in Children on Hemodialysis

      hrp0089p2-p157
    • The Role of Fibroblast Growth Factor 21 and Irisin in the Pathogenesis of Obesity in Childhood and Adolescence

      hrp0089p2-p158
    • Serum NAMPT Levels are not Associated with Parameters of Liver Function in Children and Adolescents

      hrp0089p2-p159
    • Obesogenic Environment and Their Influence on Adiposity on Mexican Children and Adolescents

      hrp0089p2-p160
    • Metabolic Alterations and Weight Status in Children at 8 Years: A Prospective Cohort Study

      hrp0089p2-p161
    • Correlation of Dietary Habits with Systolic Blood Pressure in Healthy Children

      hrp0089p2-p162
    • Evaluation of Voiding Dysfunction in Obese Children

      hrp0089p2-p163
    • Comparison of Antropometric and Biochemical Parameters in Obese Children with or without Primary Headache

      hrp0089p2-p164
    • The Protective Effect of Exclusive Breastfeeding for overweight/Obesity in Children with High Birth Weight

      hrp0089p2-p165
    • Determinants and Consequences of Exaggerated Adrenarche in Simple Obesity

      hrp0089p2-p166
    • Metabolic Alteration in Patients Affected by PseudoHypoParathyroidismo 1a (PHP1a): A Preliminary Data

      hrp0089p2-p167
    • Weight Loss Outcomes in Two-Year Multidisciplinary Lifestyle Intervention Program Involving Obese Children and their Parents

      hrp0089p2-p168
    • Relationship between Glucose and Lipid Metabolism, Inflammatory Factors and Adipokines in Children with Obesity

      hrp0089p2-p169
    • Development of Resistance to Sorafenib, a Multikinase Inhibitor, in Hepatocellular Carcinoma is Mediated by SIRT

      hrp0089p2-p170
    • Gender and Pubertal Tendencies of Plasma leptin and Dopamine Levels Depending on TaqIA DRD2 Gene Polymorphism in the Different Pediatric Obesity Classes

      hrp0089p2-p171
    • Iron Metabolism Disorders in Prepubertal Obese Children with and Without NAFLD

      hrp0089p2-p172
    • Familial Hypercholesterolemia Due to Homozygous LDLRAP1 Mutation: Variability of Phenotype and Response to Medical Therapy

      hrp0089p2-p173
    • CAN Triponderal Mass Index be a New Indicator in the Predicting Cardiometabolic Risk in Obese Adolescents?

      hrp0089p2-p174
    • Social Networks, Social Support and Weight-Related Outcomes among Adolescents

      hrp0089p2-p175
    • Identification of A Novel Homozygous Mutation in BBS10 in Five Children With Bardet-Biedl Syndrome

      hrp0089p2-p176
    • The Effects of the Birth Weight on the Fat Distribution and Fatness Parameters of the Body

      hrp0089p2-p177
    • Oxidative Homeostasis Dysregulation May Promote Pathogenesis of Cardio-metabolic Complications in Childhood Obesity

      hrp0089p2-p178
    • Body Composition Parameters, Systemic Inflammation and Metabolic Syndrome Manifestations in Children and Adolescents

      hrp0089p2-p179
    • Relationships between Obesity Parameters and Urinary Concentrations of Phthalates and Phenols in Korean Girls

      hrp0089p2-p180
  • Fat, Metabolism and Obesity P3
  • • NKX2-2 Human Mutation Causes Neonatal Diabetes followed by Severe Infantile Obesity Associated with Paradoxical Upregulated Ghrelin Levels - Do Beta-cells Secrete Ghrelin?

      hrp0089p3-p125
    • Tracing the Effect of the Melanocortin-4 Receptor Pathway in Obesity: Study Design and Methodology of the TEMPO Registry

      hrp0089p3-p126
    • BigO: Big Data Against Childhood Obesity

      hrp0089p3-p127
    • Exposure to Bisphenol-A and Phtalates in Obese Girls

      hrp0089p3-p128
    • Obesity of Childhood and Ambulatory Glucose Monitorization

      hrp0089p3-p129
    • Familial Partial Lipodystrophy, Importance of Family History - A Case Report

      hrp0089p3-p130
    • Development of Severe Obesity in a Children with a Brainstem Tumor

      hrp0089p3-p131
    • Correlation Between Obesity, BMI and Insulin Resistance in Bulgarian Children

      hrp0089p3-p132
    • Nonclassical Manifestation of PWS

      hrp0089p3-p133
    • Metabolic Parameters in Children with Syndromic Obesity

      hrp0089p3-p134
    • Cut-off for the Follow-up of Obese Children: Cynicism or Realism?

      hrp0089p3-p135
    • Proximal Microdelection 16p11.2 Syndrome

      hrp0089p3-p136
    • The Level of the Vitamin D and Metabolic Status in Children with Obesity

      hrp0089p3-p137
    • A Compound Heterozygote Mutation in a Chinese Patient Affected with Methylmalonic Acidemia

      hrp0089p3-p138
    • Lymposomal Acid Lipase Deficit in Patients with Hypercholesterolemia

      hrp0089p3-p139
    • Hepatic Steatosis and its Relationship with the Metabolic Syndrome

      hrp0089p3-p140
    • Serum Hepcidin and Ferritin in Prepubertal Obese Children

      hrp0089p3-p141
    • Osse Registry for Patients with Lipodystrophy Run by the European Consortium of Lipodystrophy (ECLip)

      hrp0089p3-p142
    • Acanthosis Nigricans in Obese Children and Adolescents in relation to Severity of Obesity and Insulin Resistance

      hrp0089p3-p143
    • Serum Uric Acid and Its Correlation with Metabolic Syndrome Factors in Simple Obesity Children

      hrp0089p3-p144
    • Thyroid Function, Lipid Profile and Carbohydrate Metabolism Parameters in Patients with Alstrom Syndrome

      hrp0089p3-p145
    • Does the Level of Studies of Parents Influence the Follow-up of the Recommendations of the Nutritional Pyramid?

      hrp0089p3-p146
    • Bariatric Surgery as Treatment of Primary Pseudotumor cerebriin a Male Adolescent: Case Report

      hrp0089p3-p147
    • Investigation of Pubertal Effect on Thyroid Volume and IGF-1 Changes in Morbid Obese Children

      hrp0089p3-p148
    • The Effect of Vitamin D Supplementation on Metabolic Syndrome Parameters in Overweight and Obese Children and Adolescents in Greece

      hrp0089p3-p149
    • Mother's Obesity and High Child's Waist Circumference are Predictive Factors of Severe Child's Obesity: An Observational Study in French Guiana

      hrp0089p3-p150
    • Lipidogram, Leptin-and Adiponectinaemia in Teenagers and Adolescents with Metabolic Syndrome

      hrp0089p3-p151
    • Metabolic Endotoxemia in Egyptian Obese Children and Adolescents

      hrp0089p3-p152
    • Resting Metabolic Rate and the Development of Metabolic Disorders in Obese Children

      hrp0089p3-p153
    • Relation of Screen-Time (Phone-Computer-TV-Online Games) and Physical Activity with Childhood Obesity

      hrp0089p3-p154
    • Effect of Three-Month Diet and Physical Activity on Adipokines and Inflammatory Status in Children with Metabolic syndrome

      hrp0089p3-p155
    • Neck Circumference and Lipid Profile in Adolescents with Overweight/Obesity

      hrp0089p3-p156
    • A Not So 'Simple Obesity'

      hrp0089p3-p157
    • Effect of Obesity on Bone Age and Hormonal Parameters in Indian Children

      hrp0089p3-p158
    • Compliance of Obese Children and Their Family to the Directions of a Pediatric Endocrinology Medical Office

      hrp0089p3-p159
    • Risk Factors and Comorbidities of Childhood Obesity

      hrp0089p3-p160
    • Autonomic Nervous System - Inflammation Link: A New Independent Mechanism for Homeostasis

      hrp0089p3-p161
    • Effects of a Brief Physician Delivered Counseling on Childhood Obesity

      hrp0089p3-p162
    • The Prevalence of Obesity in Boys in the Region of the Russian Federation

      hrp0089p3-p163
    • Obesity in Adolescents, is Accompanied by a High Levels of Leptin and a Low Serum Ghr Level in the Blood Plasma. A High Degree of Obesity is Accompanied by a Greater Higher Leptin Level and Decrease in the Ghr Level. These Changes are More Significant Registered in Abdominal Ob

      hrp0089p3-p164
    • Hidden Hunger in Overweight/obese Indian Adolescents

      hrp0089p3-p165
    • Assessment of Obesity in Children with Achondroplasia and Hypochondroplasia

      hrp0089p3-p166
    • Correlation of Lipoprotein(a) Levels and Family History of Cardiovascular Disease in a Sample of Overweight/obese Children and Adolescents

      hrp0089p3-p167
    • Beneficial Effect of Metformin Treatment in Obese Children and Adolescents

      hrp0089p3-p168
    • Comparison of the Effectiveness of a Battery Powered and Manual Toothbrush in Removal of a Dental Plaque for Good Oral Hygiene in Adolesents with Over-Weight

      hrp0089p3-p169
  • Fetal, Neonatal Endocrinology and Metabolism P1
  • • Cardiac and Vascular Assessments in Small- vs Appropriate-for-Gestational-Age Infants at Ages 1 and 2 Years

      hrp0089p1-p135
    • Bone Maturation as a Predictive Factor of Catch-up Growth During the First Year of Life in Born Small for Gestational Age Infants: A Prospective Study

      hrp0089p1-p136
    • Neonatal Screening Tests in Premature Newborns in Southern Brasil

      hrp0089p1-p137
    • Measurement of Estradiol and Testosterone in Umbilical Cord Blood by Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS); Comparisons with Radioimmunoassay (RIA)

      hrp0089p1-p138
    • Transient Neonatal Iatrogenic Hypothyroidism due to Iodinated Contrast

      hrp0089p1-p139
    • Sexual Dimorphism of IGF1 and IGF2 Expression in the Neonatal Rat Brain

      hrp0089p1-p140
  • Fetal, Neonatal Endocrinology and Metabolism P2
  • • Clinical characteristics of Congenital Hyperinsulinism Caused by Dominant KCNJ11/ABCC8 Mutations

      hrp0089p2-p181
    • Clinical Characterstics, Genotype-Phenotype Correlations and Follow Up of Patients with Congenital Hyperinsulinaemic Hypoglycaemia; Single Center Experience from a Southeastern City of Turkey

      hrp0089p2-p182
    • Congenital Hyperinsulinism: Management and Outcome in West of Scotland

      hrp0089p2-p183
    • 20 Cases of Congenital Hyperinsulinism in Ukraine

      hrp0089p2-p184
    • Nifedipine Therapy in Hyperinsulinaemic Hypoglycaemia Due to Mutations in the PMM2 Gene Improves Fast Tolerance, Stabilises Blood Glucose Profile, and Enables Rationalisation of Treatments for Glycaemic Control and Hypertension: The First Reported Trial in 3 Patients in a Tertiary Centre

      hrp0089p2-p185
    • Potentially Modifiable Predictors of Adverse Neonatal Outcomes in Women with Gestational Diabetes Mellitus (GDM)

      hrp0089p2-p186
    • A Boy with Diazoxide Unresponsive Congenital Hyperinsulinism due to a Homozygous ABCC8 Missense Mutation Previously Reported to be Dominant

      hrp0089p2-p187
    • Diazoxide Unresponsive Congenital Hyperinsulinism due to a Novel ABCC8 Missense Mutation

      hrp0089p2-p188
    • Neonatal Hypoglycaemia: Unchanged Risk of Neurodevelopmental Impairment, But Sex-Specific Decreased Fine Motor Function and Increased Internalizing Behaviour at School Age

      hrp0089p2-p189
    • Atypical Hepatoblastoma and Wilm's Tumour in an Infant with Beckwith-Wiedemann Syndrome and Diazoxide Resistant Congenital Hyperinsulinism

      hrp0089p2-p190
    • Association between Rubenstein-Taybi Syndrome and Hyperinsulinaemic Hypoglycaemia

      hrp0089p2-p191
    • Hyperinsulinemic Hypoglycemia in Congenital Disorder of Glycosylation Type-1a (CDG-1a)

      hrp0089p2-p192
    • A Rare Cause of Hyperinsulinemic Hypoglycemia: Costello Syndrome

      hrp0089p2-p193
    • Molecular Defects Identified by Whole Exome Sequencing in a Chinese Boy with Fructose-1,6-Bisphosphatase Deficiency

      hrp0089p2-p194
    • The Benefit of Universal Neonatal Screening for Hypoglycemia

      hrp0089p2-p195
    • Prematurity of 23 or Less Weeks' Gestation is a Risk for Transient Late-Onset Hyperglycemia in Neonates

      hrp0089p2-p196
    • An unusual cause of neonatal hyperglycemia - case report

      hrp0089p2-p197
    • Neonatal Hypocalcemia Due to Maternal Hypovitaminosis D: A Cohort of Children in a Region of Northern Spain

      hrp0089p2-p198
    • Evaluation of Vitamin D Status and Its Correlation with Gonadal Function in Children at Mini-puberty

      hrp0089p2-p199
    • Systemic Pseudohypoaldosteronism Type 1 Due to 3 Novel Mutations in SCNN1A and SCNN1B Genes; Report of 3 Cases

      hrp0089p2-p200
    • Postnatal Growth of Infants with Neonatal Diabetes: Insulin Pump (CSII) Versus Multiple Daily Injection (MDI) Therapy

      hrp0089p2-p201
    • Serum Vaspin Concentration in Full-term, Appropriate-for-Gestational-Age Newborns: Effect of Early-Onset Infections

      hrp0089p2-p202
    • First Three Years of The Congenital Adrenal Hyperplasia Neonatal Screening Program of the State of Parana, Southern Brazil

      hrp0089p2-p203
    • Assessment of the Stretched Penile Length in Sri Lankan Newborns

      hrp0089p2-p204
    • Auxological Catch Up Growth and Evaluation of Spontaneous Motility in the Term Newborn Small for Gestational Age Employing the Prechtl Assessment of General Movements

      hrp0089p2-p205
  • Fetal, Neonatal Endocrinology and Metabolism P3
  • • A Rare Case of Congenital Hyperinsulinemina with ABCC8 Missense Mutation Presenting with Focal Pancreatic Lesion

      hrp0089p3-p170
    • Comparison of Metabolic Parameters of Children's Blood Depending on the Level of Mother's Glycemia During Pregnancy

      hrp0089p3-p171
    • Forty patients with persistent, non-focal congenital hyperinsulinism: Urgent need for new treatment modalities

      hrp0089p3-p172
    • Outcome of Eight Patients with Congenital Hyperinsulinism (CHI) Studied with 18[F]Dihydroxyphenyl-Alanine Positron Emission Tomography Imaging (18F-DOPA-PET-CT) in Argentina

      hrp0089p3-p173
    • Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination

      hrp0089p3-p174
    • Neonatal Diabetes Mellitus in Vietnam National Children Hospital

      hrp0089p3-p175
    • Axillary Temperature Relation to Blood Serum Insulin-like Growth Factor-I in the Not-life-Threatened Newborn: Relevance of Preterm Birth

      hrp0089p3-p176
    • Birth Estimated Brain Weight Relation to Ratios between Insulin-like Growth Factor-II and Insulin-like Growth Factor Binding Protein-3 in the Not-life-threatened Newborn: Relevance

      hrp0089p3-p177
    • Congenital Hyperinsulinism in Children with Beckwith-Wiedemann Syndrome

      hrp0089p3-p178
    • Comparison of the Phenylketonuria Phenotypes in Qazvin Province Before and After Neonatal Screening Until 2017

      hrp0089p3-p179
    • From Hypoglycemia to Hyperglycemia

      hrp0089p3-p180
    • Population Screening of Hypophosphatasia. A Metabolopathy to Consider. National Multicentric Study

      hrp0089p3-p181
    • Dumping Syndrome in a Neonate with Esophagical Atresia Surgery

      hrp0089p3-p182
    • Diagnosis and Treatment of Persistent Hyperkalemia in Newborn Twins - Rare Case Report of Gordon Syndrome

      hrp0089p3-p183
    • Mutation in UCP2 Gene: A Rare Cause of Hyperinsulinemic Hypoglycaemia Syndrome in a Small-for-Gestational Age Newborn

      hrp0089p3-p184
    • Hyperinsulinemic Hypoglycaemia Syndrome in Small-for-Gestational Age Newborns: Clinical Characteristics and Genetic Study

      hrp0089p3-p185
    • Pediatric Insulinoma: A Case Report

      hrp0089p3-p186
    • Mutations in Indian children with Neonatal Diabetes

      hrp0089p3-p187
    • Weight Outcome in Infants with Prolonged Hyperinsulinemic Hypoglycemia Treated with Diazoxide vs Those with Spontaneous Resolution

      hrp0089p3-p188
    • Neonatal Hyper- and Hypoglycaemia; Widening the Clinical Phenotype of Transient Neonatal Diabetes Mellitus due to 6q24 Methylation Defects

      hrp0089p3-p189
    • Clinical and Molecular Genetic Characterization of Two Patients due to Mutations

      hrp0089p3-p190
    • Transient Central Hypothyroidism due to Maternal Graves' Disease

      hrp0089p3-p191
  • GH & IGFs P1
  • • Autosomal Dominant Growth Hormone Deficiency due to a Novel c.178G>A Mutation in the GH1 Gene Causing Instability of the Mutant GH Protein (p.Ala34Thr)

      hrp0089p1-p141
    • Growth Hormone Deficiency due to Whole-Gene Deletion of GHRHR

      hrp0089p1-p142
    • Severe Pre- and Postnatal Growth Retardation in a Child Harboring a Novel Homozygous IGF1 Gene Mutation

      hrp0089p1-p143
    • A New p.(Ile66Serfs*93) IGF2 Variant Is Associated with SRS-like Phenotype

      hrp0089p1-p144
    • Response to Growth Hormone in Patients with Isolated Familial Growth Hormone Deficiency due to RNPC3 Mutations

      hrp0089p1-p145
    • Laron Syndrome Patients have an Abnormal Plasma Amino Acid Pattern

      hrp0089p1-p146
    • Serum IGFBP-2 Concentration in Neonates with Potential Diagnosis of Growth Hormone Deficiency (GHD)

      hrp0089p1-p147
    • GH Treatment Causes an Increase in Klotho Concentration in Children with Growth Hormone Deficiency

      hrp0089p1-p148
    • Assesment of SDF-1 and Ang-1 and Ang-2 in Children with Growth Hormone Deficiency before and after 1- year Therapy with Recombinant Growth Hormone

      hrp0089p1-p149
    • Total Sum of Growth Hormone Values Obtained from Growth Hormone Stimulation Test May be Useful in the Diagnosis of Prepubertal Children with Idiopathic Growth Hormone Deficiency

      hrp0089p1-p150
    • Growth of Premature Infants Born Small by Gestational Age

      hrp0089p1-p151
    • Microalbuminuria and Glomerular Filtration Rate in SGA Born Young Adults

      hrp0089p1-p152
    • Testing the Performance of a Preexisting Growth Prediction Model in a Cohort of Prepubertal Patients Born Small for Gestational Age (SGA) Receiving GH Treatment in PATRO Children

      hrp0089p1-p153
    • Early Onset GH Replacement in GH Deficiency: Is Neonatal Hypoglycemia Important for Long Term Follow-Up?

      hrp0089p1-p154
    • Prevalence of Diabetes among Children Treated with Growth Hormone in Israel

      hrp0089p1-p155
    • The Effect of Growth Hormone Treatment in Children after Hematopoietic Stem Cell Transplantation

      hrp0089p1-p156
    • EasypodTM Connect Observational Study: The Italian Experience

      hrp0089p1-p157
    • Patients and Caregivers Perspectives on a Mobile App that Tracks Adherence and Outcomes in Children with Growth Disorders Treated with Recombinant Human Growth Hormone (r-hGH)

      hrp0089p1-p158
  • GH & IGFs P2
  • • Identification of Three Novel GLI2 Gene Variants Associated with Hypopituitarism

      hrp0089p2-p206
    • Clinical and Preliminary Molecular Description of a Cohort of Patients with Growth Retardation due to Severe Primary IGF1 Deficiency (GROWPATI Study)

      hrp0089p2-p207
    • A Novel, Synonymous, Heterozygous, Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor: Causality for Mild Growth Impairment and IGF-I Deficiency in an Affected Patient?

      hrp0089p2-p208
    • A Novel Mutation of Type I Insulin-like Growth Factor Receptor (IGF1R) Gene in a Severe Short Stature Pedigree Identified by Targeted Next-generation Sequencing (NGS)

      hrp0089p2-p209
    • Severe Short Stature, Growth Hormone (GH) Deficiency, Hypospadias, and Microcephaly: New Insights into the Role of Chromosome 4 Long Arm Duplication

      hrp0089p2-p210
    • Growth Hormone Treatment for Short Stature Associated with TRNT1 Deficiency: A Case Series

      hrp0089p2-p211
    • Case Report: Novel Case of Short Stature and Co-occurrence of SHOX Gene Mutation and Fanconi Anemia

      hrp0089p2-p212
    • Different Genetic Causes of Short Stature in a Family

      hrp0089p2-p213
    • Incidence of Cranial MRI Abnormalities in Patients with Isolated Growth Hormone Deficiency: 20 Years of Results

      hrp0089p2-p214
    • Systematic Prospective Study of Eye Funduscopy Before and After Starting Treatment with Growth Hormone in 290 Patients

      hrp0089p2-p215
    • Incidence and Prevalence of GH Deficiency in the Russian Federation - An Analysis of Two Registries

      hrp0089p2-p216
    • The BSPED National GH Audit: Trends in Prescribing from 2013-2016

      hrp0089p2-p217
    • The Rationale and Design of TransCon GH

      hrp0089p2-p218
    • Baseline Demographics of the TransCon GH Phase 3 heiGHt Trial

      hrp0089p2-p219
    • The ZOMATRIP Study: Four Year Combination Therapy of GH and GnRHa in Girls with a Short Predicted Adult Height During Early Puberty: Adult Height Outcome

      hrp0089p2-p220
    • Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

      hrp0089p2-p221
    • Height Perception of Children with GH Deficiency: Influencing Factors and Links to Psychosocial Functioning

      hrp0089p2-p222
    • Health Lifestyle and Obesity of Adult Patients with Congenital Isolated Growth Hormone Deficiency Treated in Childhood

      hrp0089p2-p223
    • Factors Influencing Health Related Quality of Life in Children/Adolescents with GH Deficiency

      hrp0089p2-p224
    • Health-Related Quality of Life and Psychosocial Functioning in Young Adults Born SGA after GH/GnRHa Treatment

      hrp0089p2-p225
    • Adherence to Treatment in Growth Hormone Deficient and Small for Gestational Age Patients Naive to EasypodTM in Mexico: Final Results of the EasypodTM Connect Observational Study (ECOS)

      hrp0089p2-p226
    • Growth Pattern and Final Height Outcome in Children with Septo-optic Dysplasia and Isolated Hypopituitarism Treated with rhGH in a Single Centre

      hrp0089p2-p227
    • Reliability of Clonidine Testing for the Diagnosis of Growth Hormone Deficiency in Children and Adolescents

      hrp0089p2-p228
    • Area under the Curve of Growth Hormone, An Additional Tool in Assessing Stimulation Test Results

      hrp0089p2-p229
    • Evaluation of Spontaneous Nocturnal GH Secretion: Noe Versus Two Consecutive Nights

      hrp0089p2-p230
    • Relationship between Growth Velocity and Change of Serum Insulin-Like Growth Factor-1 (IGF-1), Serum IGF Binding Protein-3 (IGFBP-3) Concentrations, and IGFBP-3 Promoter Polymorphism during Gonadotropin-Releasing Hormone Agonist (GnRHa) Treatment

      hrp0089p2-p231
    • The Predictive Role of IGF-1 on Irradiation-Dependent Growth Hormone Deficiency (GHD) in Childhood Cancer Survivors (CCS)

      hrp0089p2-p232
    • Effects of Zinc, Magnesium and Vitamin B6 (ZMA) Supplementation on Serum IGF-I, IGFBP-3 and Testosterone Concentrations in Young Athletes

      hrp0089p2-p233
    • High Protein Nutritional Supplementation Increases Serum IGF-I Concentrations in Short Children with Low IGF-I

      hrp0089p2-p234
    • Hormonal Predictors of Growth Hormone Therapy Effectiveness in Children with Short Stature - Evidence from Neural Prediction Model for Final Height

      hrp0089p2-p235
    • Artificial Neural Networks for Prediction Final Height in Children with growth Hormone Deficiency

      hrp0089p2-p236
    • Predictors of Poor Response to Growth Hormone Therapy in Children with Short Stature - Evidence from Neural Prediction Model for Final Height

      hrp0089p2-p237
    • Growth Hormone Therapy and Its Challenges in GH Deficient Cases in a Multinational Population-a Sneak-Peek

      hrp0089p2-p238
  • GH & IGFs P3
  • • Good Growth Response to Growth Hormone Therapy in Short Children with Normal Growth Hormone Secretion

      hrp0089p3-p192
    • Growth Hormone Deficiency Intwo Children with Williams-Beuren Syndrome: The Long-Term Response to Growth Hormone (GH) Therapy

      hrp0089p3-p193
    • Growth Hormone Treatment: Does Timing Matter?

      hrp0089p3-p194
    • Support for Patients Treated with Growth Hormone to Reach their Growth Potential: Addressing Adherence Barriers through Personalised Behavioural Patient-support Programmes

      hrp0089p3-p195
    • Main Discrepancies between Predicted and Observed Growth Responses with iGRO in Children Treated with GHr in Spain

      hrp0089p3-p196
    • Adherence and Long-term Outcomes of Therapy in Pediatric Subjects in Greece Using Easypod™ Electromechanical Device for Growth Hormone Treatment: The Phase IV Multicentre Easypod™ Connect Observational Study (ECOS)

      hrp0089p3-p197
    • Growth Hormone Deficiency in Neurofibromatosis: Report of Four Cases

      hrp0089p3-p198
    • Extremely Low Body Mass Index Negatively Impact the Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency

      hrp0089p3-p199
    • Small for Gestational Age (SGA) Patients with Premature Treatment Discontinuation: Their Journey in French Real-life Settings

      hrp0089p3-p200
    • Effects on Near-adult Height and Safety of Recombinant Human Growth Hormone in Growth Hormone Deficiency and Turner Syndrome Patients: Results from the LG Growth Study

      hrp0089p3-p201
    • Final Adult Height After Growth Hormone Treatment in Patients with Turner Syndrome

      hrp0089p3-p202
    • Results of Mecasermin Treatment in Pediatric Patients Evaluated for Severe and Partial Primary Deficiency of IGF-1

      hrp0089p3-p203
    • Children Born Small for Gestational Age Treated with Growth Hormone: Evolutionary Aspects

      hrp0089p3-p204
    • Small for Gestational Age (SGA) Patients in Real Life French Clinical Practice: What is the Difference Between Good and Poor Responders to GH Treatment

      hrp0089p3-p205
    • Body Mass Index (BMI) in Patients with Growth Hormone Deficiency (GHD) at Diagnosis, One Year and Two Years After Treatment with Growth Hormone (GH)

      hrp0089p3-p206
    • Erythropoietin and Granulocyte Macrophage Colony Stimulating Factor Levels in Growth Hormone Deficient Children after 1 Year of Growth Hormone Therapy

      hrp0089p3-p207
    • Cost-effectiveness of Growth Hormone Therapy in Children in Russia

      hrp0089p3-p208
    • Vitamin D Status in Children with Isolated Idiopathic GH Deficiency (GHD) in North and Central Greece

      hrp0089p3-p209
    • A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency